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POTATO AND GRAPE POLYPHENOLS, RESPECTIVELY, SUPPRESS HIGH-FAT DIET-
ELEVATED OXIDATIVE STRESS/INNATE INFLAMMATION MARKERS IN PORCINE 
MODEL AND INDUCE APOPTOSIS IN HCT-116 P53 +/+ AND P53 -/- HUMAN COLON 
CANCER CELL LINES IN VITRO 
Rationale 
In Vitro Study 
Bioactive compounds from fruits and vegetables have demonstrated anti-inflammatory, 
anti-oxidant and anti-cancer properties. Grapes and purple-fleshed potatoes are rich sources of 
polyphenols. Grape seed extract (GSE) a popular dietary supplement rich in proanthocyanidins, 
demonstrated anti-cancer properties in a variety of in vitro and in vivo models. Red grapes are 
rich in resveratrol (RSV), a compound that has shown anti-oxidant, anti-inflammatory and anti-
cancer properties in a variety of models including human studies. We previously reported that 
RSV suppressed proliferation, and induced apoptosis via p53 activation in human colon cancer 
cell lines HT-29 and SW-480, however, only at high concentration > 75-100 µM. Since bioactive 
compounds exist as a complex mixture in fruits and vegetables with synergistic or additive 
chemopreventive/protective actions, we hypothesized that the combination of RSV and GSE 
would be a more potent mixture with efficacy at lower concentrations. We tested anti-cancer 
efficacy of RSV and GSE, alone and in combination, in HCT-116 p53 +/+ and -/- human colon 
cancer cells. We tested anti-cancer efficacy of RSV and GSE in the presence of IGF-1, a mitogen 







High-fat diet (HFD) consumption is linked to elevated risk for a variety of disorders. 
HFD elevated oxidative stress and inflammation and provides conducive environment for 
chronic disorders such as colon cancer. Dietary modification can help reduce risk for such 
conditions. Indeed, higher consumption of bioactive compounds present in fruits and vegetables 
are inversely associated with risk for such inflammatory disorders. The potato is the third largest 
source of phenolic compounds in the human diet after oranges and apples. Purple-fleshed 
potatoes are rich in anthocyanins and phenolic acids with anti-oxidant and anti-inflammatory 
properties. Unlike other anthocyanin-rich sources such as blueberries, purple-fleshed potatoes are 
relatively inexpensive and widely available, but they are almost always consumed in processed 
form. Thus, it is important to understand the effect of processing on purple-fleshed potato 
bioactive compounds before we present it as a functional food – a delivery vehicle for health 
promoting bioactive constituents. The overall goal of these studies was to determine the extent to 
which purple-fleshed potato consumption, even after processing, prevent or reverse HFD 
elevated oxidative stress and innate inflammatory markers (colon, mesenteric fat and systemic 
circulation) in a pig model. 
 
Animal Study Experiment Design 
We hypothesized that consumption of purple-fleshed potatoes, even after processing, will 
suppress HFD elevated colonic, mesenteric fat and systemic oxidative stress/inflammation 
markers in the pig model compared to white-fleshed potatoes and HFD control. To test this 
hypothesis, we performed two studies – a prevention study where 64 pigs, 3 weeks post-





raw, baked or chipped purple or white-fleshed potatoes (10 % w/w) for 13 weeks; and a reversal 
study where pigs (12 weeks on HFD) consumed HFD containing 10/20 % purple or white-
fleshed potato chips for additional 5 weeks (n = 8).  
 
Results and Conclusions 
In Vitro Study 
Our results demonstrated that RSV (~ 25 µM) and GSE (35-50 µg/ml) mixture is potent 
in suppressing proliferation and elevating apoptosis in HCT-116 p53 +/+ human colon cancer 
cell lines at lower concentrations compared to RSV or GSE alone. RSV potentiated GSE induced 
p53 dependent apoptosis via mitochondrial apoptotic signaling as evidenced by elevated 
Bax:Bcl-2 ratio, reactive oxygen species and activated caspase-3. The RSV-GSE combination 
suppressed proliferation and induced apoptosis even in presence of IGF-1 (elevated during 
obesity), suggesting its potential role as a chemopreventive agent against IGF-1 promoted colon 
cancer. Moreover, RSV-GSE did not suppress proliferation or induce apoptosis in normal 
colonic epithelial cell line CRL-1831, demonstrating its specificity to cancer cells. These results 
strongly support our hypothesis that combining bioactive compounds like RSV and GSE could 
provide similar or better anti-colon cancer properties compared to individual compounds at lower 
concentrations. This lends support to the proposal that combinatorial approach towards colon 
cancer chemoprevention using bioactive compounds is a feasible approach. However, animal 









In the prevention study, only the purple-fleshed potato raw group had significantly lower 
distal colonic and mesenteric fat oxidative stress (measured using GSH:GSSG ratio, a sensitive 
marker for oxidative stress) compared to the HFD control. However, all the potato diets 
consuming animals had suppressed (P ≤ 0.05) distal colonic and mesenteric fat expression of 
innate inflammatory markers TLR-4, NF-B, and TNF-α compared to the HFD control and 
similar to that of SD control animals. Animals consuming potato diets had significantly 
suppressed urinary 8-isoprostane (8IP) and DNA adduct 8-OHDG (Enzyme immunoassay), and 
serum TNF-α (ELISA) and IL-1β (Milliplex immunoassay) compared to the HFD control 
animals. In the reversal study, the markers of distal colonic and systemic oxidative stress and 
inflammation were consistently suppressed only in the purple-fleshed potato consuming groups 
compared to HFD controls (P ≤ 0.05), suggesting that time of intervention is very important. 
Results from both studies show that only the purple-fleshed potato, even after processing, 
prevented and reversed HFD elevated oxidative stress/inflammation markers in the distal colon, 
mesenteric fat and systemic circulation, in the pig – a human relevant animal model. Thus, 
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Although some dietary fat is necessary for health, in countries like the US, the major 
issue is consuming too much rather than too little. It is commonly pointed out that people in the 
US have reduced their percentage of calories from fat over the last three decades; however, 
actual fat consumption (i.e., grams of fat per day) has remained quite high since the 1960s. The 
reduction in fat percentage is due to the fact that total calorie intake has increased rather than that 
fat intake has decreased (for men, average energy intake increased from 2,450 kcals to 2,618 
kcals, and for women, from 1,542 kcals to 1,877 kcals (CDC 2004)). Excess dietary fat 
consumption is a concern because considerable research suggests that higher dietary fat 
consumption can lead to oxidative stress, elevated innate inflammatory response, and increased 
risk for chronic disease such as colon cancer (Reddy 2002, Lovejoy 2010, Silviera, Smith et al. 
2012). Dietary modification can help reduce risk for such conditions. Increased consumption of 
bioactive compounds present in fruits and vegetables are inversely correlated with chronic 
disease risk (Hooper and Cassidy 2006, Pan, Lai et al. 2009). Plant bioactive compounds such as 
anthocyanins, proanthocyanidins, and stilbenoids like resveratrol (RSV) have shown to possess 
anti-inflammatory and anti-cancer properties in multiple in vitro and in vivo studies (Kowalczyk, 
Krzesinski et al. 2003, Cooke, Schwarz et al. 2006, Kaur, Singh et al. 2006, Vanamala, Reddivari 
et al. 2010). Grapes (proanthocyanidins and RSV), and purple-fleshed potatoes (anthocyanins 
and phenolic acids) are attractive delivery vehicles for these bioactive compounds as they are one 





RSV and grape seed extract (GSE, rich in proanthocyanidins, typically lacks RSV) have 
demonstrated anti-cancer properties in both in vitro and in vivo models. They have shown to alter 
p53 related pathways in suppression of colon cancer cell proliferation and induction of apoptosis 
typically at high concentrations difficult to achieve with dietary supplementation (Agarwal, 
Singh et al. 2002, Laurent, Besancon et al. 2004, Kaur, Singh et al. 2006, Kaur, Mandair et al. 
2008, Vanamala, Reddivari et al. 2010, Vanamala, Radhakrishnan et al. 2011). Single bioactive 
compound approach has often failed during clinical trials to suppress colon cancer growth 
(Saldanha and Tollefsbol 2012). Therefore, there is a growing interest in using combination of 
bioactive compounds that act synergistically and at low concentrations to suppress cancer 
growth. There is no direct evidence linked to the possible synergistic or additive effect (and 
mechanism of action) of the RSV-GSE combination in human colon cancer cell line HCT-116 
kinetics, especially in the presence of IGF-1, a mitogen elevated during obese conditions 
(Vanamala, Reddivari et al. 2010).   
The potato is the third largest source of phenolic compounds in the human diet after 
oranges and apples (Chun, Kim et al. 2005). Purple-fleshed potatoes are rich in anthocyanins and 
phenolic acids with anti-oxidant and anti-inflammatory properties. Unlike other anthocyanin-rich 
sources such as blueberries, purple-fleshed potatoes are relatively inexpensive and widely 
available, but they are almost always consumed in processed form (Madiwale 2012). Thus, it is 
important to understand the effect of processing on the anti-inflammatory and anti-oxidant 
properties of purple-fleshed potato bioactive compounds in vivo before we present it as a 
functional food – a delivery vehicle for health promoting bioactive compounds.  
The overall hypothesis we aimed to verify is that bioactive compounds from grapes and 





oxidative stress and inflammatory biomarkers, respectively. This hypothesis was tested using in 
vitro (human HCT-116 colon cancer cells) and in vivo (pig) models, respectively.  
 
1.1 Aims 
Aim 1: Determine if RSV and GSE synergistically suppress human HCT-116 colon cancer 
cell proliferation and induce apoptosis and determine the mechanisms of action of the 
combination. 
 
Approach: Human colon cancer cells (HCT-116 p53 +/+ and p53 -/-) and normal colon 
epithelial cells (CRL-1831) treated with bioactive compounds from grapes (RSV, GSE) at 
different concentrations alone or in combination were assayed for their anti-proliferative and pro-
apoptotic effects. We used inhibitor assays and western blotting technique to elucidate 
mechanisms of action of the RSV-GSE combination. Efficacy of RSV-GSE combination in 
presence of IGF-1 was also determined. 
 
Outcomes: This in vitro study determines 1) whether addition of RSV to proanthocyanidin-rich 
GSE, which lacks RSV, potentiates the chemopreventive properties of GSE; 2) whether the 
RSV-GSE combination induces apoptosis and arrests the cell proliferation selectively in cancer 
cells not in the normal human colon epithelial cells; 3) if the RSV-GSE combination works even 
in the presence of IGF-1 and 4) molecular mechanisms underlying anti-cancer properties of the 
grape compounds in combination. These in vitro data will facilitate future in vivo studies to 






Aim 2: Determine extent to which purple-fleshed potato consumption, even after 
processing, prevents or reverses HFD elevated oxidative stress, and innate inflammation 
markers in a pig model.  
 
Approach: We performed two studies – a prevention study where 64 pigs, 3 weeks post-
weaning, consumed one of the eight diets (n = 8): standard diet (SD), HFD and HFD 
supplemented with raw, baked or chipped purple or white-fleshed potatoes (10 % w/w) for 13 
weeks; and a reversal study where pigs (12 weeks on HFD after 3 week post weaning period) 
consumed HFD containing 10/20 % purple or white-fleshed potato chips for additional 5 weeks 
(n = 8). Samples (distal colon mucosa, mesenteric fat, serum, urine) were assayed for markers of 
oxidative stress and inflammation. The pig with nutrient metabolism and gut structure 
anatomically and physiologically similar to humans was used in the study (Houpt, Houpt et al. 
1979).  
 
Outcomes: Elevated oxidative stress and inflammation markers in the colon, mesenteric fat and 
systemic circulation are central to progression of various chronic diseases. This study provided 
first in vivo evidence that delivery of anti-inflammatory and anti-oxidant bioactive compounds 
using purple-fleshed potatoes may potentially reduce risk for chronic diseases such as colonic 
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REVIEW OF LITERATURE 
 
PART 1 – SYNERGY OF BIOACTIVE COMPOUNDS AGAINST COLON CANCER 
 
2.1 General Overview of Bioactive Compounds 
Bioactive compounds are secondary metabolites of plants that target physiological or 
cellular pathways and provide a beneficial health effect. Bioactive compounds typically occur in 
small amounts in foods, however, it is estimated that almost 0.2–1 g/day of these compounds are 
consumed as part of a regular healthy diet (Kris-Etherton, Hecker et al. 2002, Kris-Etherton, 
Lefevre et al. 2004). They belong to different classes and include phenolic acids, anthocyanins, 
carotenoids, stilbenes, glucosinolates, etc. They are found in fruits, vegetables, nuts, herbs etc., 
and in commonly consumed beverages such as wine, tea, and coffee. These compounds have 
demonstrated anti-oxidant and anti-inflammatory properties via targeting enzymes, cell surface 
and intracellular receptors, and by influencing gene expression, among other actions (Kris-
Etherton, Hecker et al. 2002, Kris-Etherton, Lefevre et al. 2004). There has been wide interest in 
the field of bioactive compounds as they have been linked to a reduced risk for a variety of 
chronic diseases including cancer (Kris-Etherton, Hecker et al. 2002, Kris-Etherton, Lefevre et 
al. 2004). Moreover, they fit the characteristics of an ideal chemopreventive agent, as these 
compounds are selective to cancerous or precancerous cells, target most types of cancers, can be 






2.2 Colon Cancer 
Colon cancer is the 3rd most prevalent cancer in both men and women, and accounts for 
almost 9 % of total deaths due to all cancers. Colon cancer is highly affected by environmental 
factors including diet and lifestyle. It is a concerning fact that the highest incidence rates of colon 
cancer are observed in developed nations including the US (Marshall 2008). Studies dealing with 
the migration of individuals from developing nations (colon cancer risk is low) to developed 
countries have seen that within one generation, risk for colon cancer in these individuals is 
elevated (Marshall 2008). In addition, colon cancer rates are rapidly rising in developing nations 
and could be due to adoption of several features of the western lifestyle (Marshall 2008). 
Western dietary and lifestyle factors are linked to high incidence of colorectal cancer in 
developed countries. Diets rich in red and processed meat, refined starches, sugar, and saturated 
and trans-fatty acids but poor in fruits, vegetables, fiber, omega-3 fatty acids and whole grains 
are closely associated with an increased risk of colon cancer (Bruce, Wolever et al. 2000, 
Marshall 2008, Cappellani, Zanghi et al. 2013).  
However, these factors are highly controllable and thus, colon cancer is highly 
preventable. Nutritional recommendations from the American Cancer Society include adequate 
intake of fruits and vegetable in a regular diet (Society 2012). A meta-analysis of case-control 
studies suggests that fruit and vegetable consumption in general is associated with a slight 
decrease in the risk of colon cancer (Marshall 2008). For example, fruit consumption was 
associated with a 13% decrease in colon cancer risk, and vegetable consumption was associated 
with a 40% decrease (Marshall 2008). Thus, the benefits from consuming a diet rich in fruit and 







Resveratrol (trans-3, 5, 4` trihydroxystilbene, RSV) is a polyphenol found in grapes and 
red wine among other plant products (Vanamala, Reddivari et al. 2010). RSV is synthesized in 
plant species in response to stress by the enzyme trihydroxystilbene synthase. Fresh grape skins 
contain 50-100 mg RSV per gram, and the concentration in wine ranges from 0.2 mg/l to 7.7 
mg/l (Osei-Mensah 2011). The epidemiological finding of an inverse relationship between 
consumption of red wine and incidence of cardiovascular disease has been called the "French 
paradox" and the benefits of red wine consumption have been attributed to RSV (Vanamala, 
Tarver et al. 2008, Vanamala, Reddivari et al. 2010). RSV has demonstrated anti-oxidant, anti-
inflammatory, anti-aging properties in a variety of studies (Baxter 2008). RSV interferes with all 
three stages of carcinogenesis: initiation, promotion and progression (Jang, Cai et al. 1997). We 
previously reported that RSV (> 100 µM) suppressed HT-29 human colon cancer cell 
proliferation and elevated apoptosis even in the presence of IGF-1 via suppression of IGF-
1R/Akt/Wnt signaling pathways and activation of p53 (Vanamala, Reddivari et al. 2010). In 
other studies, RSV (100 µM) induced apoptosis independently of p53 in HCT-116 human colon 
cancer cells via mitochondrial intrinsic apoptotic pathway (Mahyar-Roemer, Katsen et al. 2001). 
In Caco-2 human colon cancer cells, RSV (> 100 µM) inhibited growth and proliferation, 
induced caspase-3 activation and apoptosis, and induced cell cycle arrest via modulation of 
cyclins and cylin dependent kinases (Wolter, Akoglu et al. 2001).  
RSV elicited anti-cancer effects in animal and human models (Bishayee 2009). Oral 
resveratrol (200 μg/kg/day in drinking water) suppressed the number and multiplicity of 
azoxymethane-induced aberrant crypt foci, a precursor lesion for colon cancer, in the colon of 





2000). In another rat study, RSV (8 mg/kg body weight) markedly reduced the number of 1,2-
dimethylhydrazine induced aberrant crypt foci and incidence and size of tumors, possibly 
through the modulation of antioxidant defense status and activities of carcinogen-detoxifying 
enzymes (Sengottuvelan and Nalini 2006, Sengottuvelan, Senthilkumar et al. 2006, 
Sengottuvelan, Viswanathan et al. 2006). In a human study, daily oral doses of RSV at 0.5 or 1.0 
g reduced colon tumor cell proliferation by 5 % (Patel, Brown et al. 2010). Anti-cancer 
properties of RSV in a variety of in vitro and in vivo models are reviewed elsewhere (Athar, 
Back et al. 2007). 
 
2.4 Grape Seed Extract 
Grape seed extract (GSE, lacks RSV, (Radhakrishnan, Reddivari et al. 2011)) is a 
bioactive mixture that is commonly consumed as a dietary supplement and is sold in the form of 
capsules or tablets (100–500 mg). The consumer interest in GSE has been primarily due to the 
high content of antioxidants in the form of proanthocyanidins in this extract. The antioxidant 
capacity of GSE is greater than known antioxidants such as vitamin C and E (Kaur, Agarwal et 
al. 2009). Grape seed proanthocyanidins have demonstrated a wide spectrum of biological, 
pharmacological, therapeutic, and chemopreventive properties in multiple models (Kaur, 
Agarwal et al. 2009). 
Chemopreventive potential of GSE against colorectal cancer was evaluated in vitro in 
LoVo and HT-29 human colon cancer cell lines. GSE (> 50 µg/ml) suppressed the growth of 
these cancer cells. More importantly, GSE inhibited the growth of HT-29 cells in vitro as well as 
in tumor xenografts in athymic nude mice at dose of 200 mg/kg (Kaur, Singh et al. 2006). In 





significantly inhibited azoxymethane-induced colonic aberrant crypt foci in a rat dual-organ 
tumor model (Singletary and Meline 2001). GSE (0.25 – 0.5 % w/w) prevented azoxymethane-
induced colonic aberrant crypt foci formation in Fischer 344 rats and this was most likely via 
targeting β-catenin and NF-B signaling (Velmurugan, Singh et al. 2010). Grape seed extract is 
generally well tolerated when taken by mouth. It has been used safely for up to 8 weeks in 
clinical trials. Human studies on anti-cancer efficacy of GSE are however, currently lacking 
(Medicine 2012). Anti-cancer properties of GSE and their mechanisms of action are summarized 
in detail elsewhere (Kaur, Agarwal et al. 2009). 
 
2.5 Synergy of Bioactive Compounds 
Consumption of fruits and vegetables has generally been associated with a decrease in 
cancer incidence and cardiovascular disease. As a result, numerous bioactive compounds have 
been isolated and identified, and their potential health-promoting effects have been evaluated 
extensively, both in vitro and in vivo (Kris-Etherton, Hecker et al. 2002, Kris-Etherton, Lefevre 
et al. 2004, Marshall 2008, Chuang and McIntosh 2011). However, purified phytochemicals may 
not necessarily exert the same beneficial health effect compared to when the compound is in its 
food matrix and among other bioactive compounds. There is a growing body of evidence that the 
actions of phytochemicals administered as dietary supplements alone do not explain the observed 
health benefits of diets rich in fruits, vegetables and whole grains (de Kok, van Breda et al. 
2008). Relatively high doses of single bioactive agents may show potent anti-carcinogenic 
effects, however, the synergistic interactions between different dietary ingredients that potentiate 
the activities of any single constituent better explain the observed benefits of whole foods and 





study that compared GSE induced anti-cancer effects to the effects of its individual components, 
the researchers found that GSE was more potent in growth inhibition compared to its individual 
constituents epigallocatechin, procyanidins and their association (Dinicola, Cucina et al. 2012). 
Thus, the beneficial effect of fruit/vegetable consumption may not be the result of a single 
bioactive compound, but may arise from combination of different compounds.  
In addition, bioactive compounds may have pleiotropic effects that in combination reduce 
the risk of chronic disease. Different compounds might target different pathways and the net 
effect might be a greater suppression of cancer cell growth (Kris-Etherton, Lefevre et al. 2004, 
Majumdar, Banerjee et al. 2009). Over the last few years, there have been many studies on 
bioactive components and their synergistic anti-cancer effects (Mertens-Talcott, Talcott et al. 
2003, Aggarwal, Bhardwaj et al. 2004, Mertens-Talcott and Percival 2005, Vanamala, 
Glagolenko et al. 2008, Yang and Liu 2009, Chuang and McIntosh 2011, Del Follo-Martinez, 
Banerjee et al. 2013). However, there is no direct evidence linked to the possible synergistic or 
additive effect (and mechanism of action) of the grape bioactive components (RSV and GSE) in 













2.6 Aim 1 
Determine if RSV and GSE Synergistically Suppress Human HCT-116 Colon Cancer Cell 
Proliferation and Induce Apoptosis and Determine the Mechanisms of Action of the 
Combination. 
 
Approach: Human colon cancer cells (HCT-116 p53 +/+ and p53 -/-) and normal colon 
epithelial cells (CRL-1831) treated with bioactive compounds from grapes – RSV and GSE at 
different concentrations alone or in combination were assayed for proliferation, apoptosis and 
p53-dependent pathways. These in vitro data will facilitate future in vivo studies to determine the 
anti-cancer properties of grape bioactive compounds using laboratory animal models. 
Chemotherapeutic combination approaches have been used to reduce drug toxicity and 
obtain greater efficacy than the use of a single active component (Yang and Liu 2009). In a 
similar fashion, the phytochemicals in fruits could be used in combination as anti-cancer agents. 
However, there is little or no evidence for synergistic, additive, or antagonistic effects of grape 
compounds in combination against human colon cancer cells. This project provides evidence for 
the in vitro anti-cancer actions of the RSV-GSE combination which is already marketed as a 










PART 2 – POTATO BIOACTIVE COMPOUNDS AGAINST HIGH-FAT DIET ELEVATED 
OXIDATIVE STRESS AND INNATE INFLAMMATION 
 
2.7 Diet and Oxidative Stress/Inflammation 
Diets high in calories, especially from sugars, saturated fatty acids, and long-chain 6 
polyunsaturated fatty acids, and sedentary lifestyles contribute significantly to chronic diseases 
such as colon cancer (Chuang and McIntosh 2011). Life expectancy is predicted to decline in the 
US in the next few decades primarily due to chronic diseases now developing at early age, 
attributed mainly to poor diet and lifestyle (CDC 2009, CDC 2010).  
Colonic health is especially a major problem in countries like the US where inflammatory 
conditions, such as inflammatory bowel disease (IBD) are prevalent. The prevalence in the US of 
IBD, including Crohns disease (CD) and ulcerative colitis (UC), is greater than 200 cases per 
100,000, with the total number of IBD patients between 1 and 1.5 million (Rubin, Shaker et al. 
2012). Chronic colonic inflammation observed in UC or CD patients is a risk factor for colon 
carcinogenesis (Terzić, Grivennikov et al. 2010, Ullman and Itzkowitz 2011). Epidemiologic 
evidence suggests that high-fat diet (HFD) consumption is a risk factor for the development of 
colonic disorders, including IBD and colon cancer (Vanamala, Tarver et al. 2008, Hou, Abraham 
et al. 2011). Chronic consumption of a HFD enhances colonic oxidative stress and innate 
inflammatory (Ding, Chi et al. 2010, Kim, Gu et al. 2012) response in rats (Slavin 2013) and 
humans (Sakamoto, Kono et al. 2005, Higgins 2014). Ingestion of HFD has shown to induce 
changes in gut bacteria, alter gut permeability, leading to elevated lipopolysaccharide (LPS, a 
component of gram negative bacteria) levels and toll-like receptor (TLR-4, receptor for LPS) 





Recent papers have reported that inflammation of colonic mucosa causes inflammatory 
responses in mesenteric fat (fat surrounding intestinal segments), a key component of visceral fat 
(Karagiannides, Kokkotou et al. 2006) and in liver and other organs (Li, Lelliott et al. 2008). In 
animal models with intracolonic trinitrobenzene sulfonic acid instillations (experimentally 
induced colitis), there was elevated expression of inflammatory cytokines in the mesenteric fat 
(Karagiannides, Kokkotou et al. 2006, Gambero, Marostica et al. 2007). HFD induced 
inflammation and altered gut permeability exposes gut microbiota and their products (e.g. 
Flagellin, LPS) to the mesenteric adipose tissue. LPS induced TLR-4/NF-B innate 
inflammatory signaling has shown to promote macrophage (ATM) recruitment in the mesenteric 
fat depot. Although, other targets might be involved, current literature suggests that 
inflammation induced impaired gut barrier function and resulting leakage of microbial antigens 
induces inflammation in the mesenteric fat depot (Lam, Mitchell et al. 2011, Drouet, Dubuquoy 
et al. 2012, Kim, Gu et al. 2012). 
Adipose tissue is no longer recognized as a passive storehouse of excess energy, but an 
active endocrine and secretory organ, and a major contributor to the elevated levels of a number 
of inflammatory proteins (Li, Lelliott et al. 2008). Adipose tissue inflammation is linked to 
systemic inflammation with elevated levels of circulating cytokines such as TNF-α, IL-1β, IL-6 
etc. which are pro-inflammatory, and IL-10 and TGF-β which are anti-inflammatory (Li, Lelliott 
et al. 2008). Elevated low-grade systemic inflammation observed in animals on HFD has shown 
to be a silent killer as it forms the bedrock for development and progression of a variety of 
chronic inflammatory disorders such as rheumatoid arthritis, cancer etc. (Wilson, Finch et al. 
2002, Li, Lelliott et al. 2008, Terzic, Grivennikov et al. 2010, Chuang and McIntosh 2011). HFD 





oxidative stress/inflammation in mesenteric fat and systemic circulation could contribute to 
elevated risk for chronic diseases (Li, Lelliott et al. 2008).  
Oxidative stress plays a critical role in the pathogenesis of various diseases. Oxidative 
stress activates inflammatory pathways converging to either JNK activation or via the NF-B 
pathways (Solinas and Karin 2010). The activated inflammatory cells further release reactive 
oxygen species (ROS) and reactive nitrogen species (Nagata 2005). The excessively produced 
ROS can injure cellular biomolecules such as nucleic acids, proteins, and lipids causing cellular 
and tissue damage, which can worsen state of inflammation. Chronic low grade oxidative stress 
and inflammation are commonly observed in HFD consuming models and are conducive to 
development of disorders such as colon cancer (Furukawa, Fujita et al. 2004, Gregersen, 
Samocha-Bonet et al. 2012). Indeed, Western-style diets induced oxidative stress and 
deregulated immune responses in the colon in a mouse model of sporadic colon cancer (Erdelyi, 
Levenkova et al. 2009). 
Chronic inflammatory conditions have a long latency period and thus, there exists a 
window to institute appropriate dietary strategies and/or pharmacological interventions to 
prevent such disorders. There is a growing interest in finding natural plant-based 
strategies/agents against inflammatory disorders (Vanamala, Tarver et al. 2008). Dietary 
bioactive compounds (for e.g. anthocyanins, phenolic acids) can elicit pharmacological effects 
and can significantly alter activity of therapeutic agents by modulating biochemical pathways 
(Pan, Lai et al. 2009). Bioactive compounds like anthocyanins, phenolic acids and other 
polyphenols have shown potent anti-inflammatory properties in both animals and humans (Kim, 
Araki et al. 1998, Kowalczyk, Krzesinski et al. 2003, Baur and Sinclair 2006, Jurenka 2009, 





action which include anti-inflammatory, anti-oxidant, anti-cancer properties etc. (Kowalczyk, 
Krzesinski et al. 2003). 
 
2.8 The Potato 
The potato (Solanum tuberosum) is indigenous to the central Andean region of South 
America and was introduced to Europe by the Spanish in the 16th century. Currently, the 
potato is the world’s 4th largest food crop and the leading vegetable crop in the US, with per 
capita consumption of about 126 lbs annually (NPC 2005, 2006, NPC 2007). Potato is a good 
source of vitamins, minerals, and high quality proteins. The International Year of the Potato 
(2008) was officially launched at United Nations headquarters (New York) in October 2007 to 
focus world attention on the role potato can play in providing food security and eradicating 
poverty (UN 2008). This popularity makes potatoes and potato products an attractive “delivery 
system” for bioactive compounds in humans. However potatoes have been tarnished by bad press 
primarily due to being considered a high glycemic form of carbohydrate that could increase 
insulin resistance and risk of type 2 diabetes (Halton, Willett et al. 2006). It should be noted that 
studies providing the bad press are epidemiological and not experimental or clinical in nature.  
Potatoes accumulate a wide variety of secondary metabolites including polyphenols. The 
polyphenol content of potato tubers ranges from 530-1770 µg/gfw (Reddivari 2007). Major tuber 
phenolic acids include caffeic acid, chlorogenic acid, ferulic acid, and cryptochlorogenic acid. 
Other phenolic acids in potato include neochlorogenic acid, p-coumaric acid, and ferulic acid 
amides (Reddivari 2007). Research has reported that chlorogenic acid constitutes up to 90 % of 
the total phenolic content of potato tubers (Friedman 1997). Chlorogenic acid, caffeic acid and 





Duma et al. 2004, Chao, Mong et al. 2010, Chauhan, Satti et al. 2011). Chlorogenic acid reduced 
liver inflammation and fibrosis through inhibition of TLR-4 signaling pathway in male Sprague-
Dawley rats treated with carbon tetrachloride (CCl4 – causes hepatotoxicity). Chlorogenic acid 
suppressed CCl4 induced NF-κB activation, and hepatic mRNA expression and serum levels of 
TNF-α, IL-6 and IL-1β (Shi, Dong et al. 2013). Phenolics acids like caffeic acid have shown 
TNF-α lowering ability in vivo (Chao, Hsu et al. 2009). Caffeic acid and some of its derivatives 
such as caffeic acid phenethyl ester and octyl caffeate are potent antioxidants which present 
important anti-inflammatory actions (da Cunha, Duma et al. 2004).  
Purple-fleshed potatoes are rich in phenolic acids and anthocyanins. We (Madiwale, 
Reddivari et al. 2011, Madiwale 2012, Madiwale, Reddivari et al. 2012) and others (Rodriguez-
Saona, Giusti et al. 1998, Brown 2005) have shown that phenolic acids are present at amounts 5 
– 12 times higher in purple-fleshed potatoes compared to their white-fleshed 
counterparts. Purple-fleshed cultivars had ~ 10 – 20 times greater anti-oxidant activity compared 
to white-fleshed potatoes and could be attributed mainly to the presence of anthocyanins and 
greater amounts of phenolic acids (Radhakrishnan, Reddivari et al. 2011, Madiwale, Reddivari et 
al. 2012). However, the anthocyanin content in these specialty cultivars greatly varies by variety 
of the potato. Purple-fleshed cultivars have shown to contain anthocyanins in a wide range (6-300 
mg/100 gfw). The major anthocyanins identified were coumaryl–rutino–glucosides of petunidin, 
peonidin, malvidin and pelargonidin (Reddivari 2007).  
There are numerous reports on the anti-inflammatory properties of anthocyanins both in 
vitro and in vivo. Anthocyanins from bilberries and black currants suppressed the secretion of 
pro-inflammatory cytokines such as IL-8, MCP-1, IL-1β, IL-6, and TNF-α in in vitro and animal 





inhibited NF-B activation in monocytes and reduced plasma concentrations of pro-
inflammatory mediators in healthy adults (Karlsen, Retterstol et al. 2007). Anthocyanin-rich 
berry extracts inhibited nitric oxide production in LPS/IFN-γ activated RAW 264.7 macrophages 
(Wang and Mazza 2002). In addition, anthocyanins from different sources (cherry, berries, soy) 
have demonstrated pronounced anti-inflammatory properties in multiple models (Rossi, Serraino 
et al. 2003, Tall, Seeram et al. 2004, Han, Sekikawa et al. 2006, Nizamutdinova, Kim et al. 
2009). Reports demonstrate the anti-cancer properties of anthocyanins against colon cancer both 
in vitro and in vivo (Kang, Seeram et al. 2003, Zhao, Giusti et al. 2004, Lala, Malik et al. 2006).  
However, potato is known to contain some undesirable compounds; which are either 
naturally occurring such as glycoalkaloids (Friedman 2006), or produced by heating  during 
processing of potatoes at a high temperature like acrylamide. Glycoalkaloids found in the potato 
tubers include α-chaconine and α-solanine; which form approximately 95 % of the total 
glycoalkaloids. Glycoalkaloids are affected by pre-and postharvest factors such as poor growing 
conditions, sprouting, mechanical injury, fungal attack, exposure to light and sub-optimal storage 
conditions (Friedman 1997). However, most of freshly harvested commercial potato varieties 
contain safe levels of GAs, below the limit of 200 mg glycoalkaloids/kg of potato fresh weight 
(Knuthsen, Jensen et al. 2009).  
Processing of potato such as frying and baking generate acrylamide which is formed from 
the reaction of reducing sugars (free glucose, fructose, sucrose and hydrolyzed starch during cold 
potato storage) with amino acid asparagine via Maillard reaction, which occurs during 
processing temperature above 212 °F (Pelucchi, La Vecchia et al. 2011). Acrylamide is 
considered as a neurotoxicant and carcinogen in animal models (Friedman and Levin 2008). 





424-1739 µg/kg. Acrylamide however, is found in many foods specifically that have been 
roasted to temperatures above 120 oC (for e.g. cocoa powder and chocolate, formed during cacao 
bean roasting). Current knowledge suggests that it is difficult to consume doses high enough to 
reach toxic levels or cause cancer. However, over time, it may be possible to consume enough 
(depending on diet) to cause enough DNA damage to lead to cancer (FDA 2013).  
The potato is known for its carbohydrate content of which starch form a predominant 
percentage. A small but significant portion of this starch is resistant to digestion by enzymes in 
the stomach and small intestine, and so reaches the large intestine essentially intact where it is 
fermented by the gut bacteria to short chain fatty acids predominantly butyrate (Fung, Cosgrove 
et al. 2012, Haenen, Souza da Silva et al. 2013). This resistant starch is considered to have 
similar physiological effects and health benefits as fiber (Slavin 2013, Higgins 2014). It provides 
bulk, offers protection against colon cancer, improves glucose tolerance and insulin sensitivity, 
improves lipid profile etc. (Dias 2012). However, the amount of resistant starch in potatoes 
depends much on preparation methods. Cooking and then cooling potatoes significantly 
increases resistant starch. For example, cooked potato starch contains about 7% resistant starch, 
which increases to about 13% upon cooling (Englyst, Kingman et al. 1992). 
The potato is an important nutrient-dense component of the Western diet and represents a 
potentially very important source of energy for combating hunger around the world. Color-
fleshed potatoes offer similar profile of compounds as traditional white-fleshed potatoes, in 
addition they contain bioactive compounds such as anthocyanins and carotenoids (Brown 2005, 







2.9 Potato Processing 
It is well known that processing changes the physical and chemical composition of foods 
(Spanos, Wrolstad et al. 1990, Price, Bacon et al. 1997), thus affecting their bioactivity (Nicoli, 
Anese et al. 1999, Dewanto, Wu et al. 2002). Potatoes are almost always consumed after 
processing (baked, chipped, fried, boiled or microwaved) making it critical to understand the 
effect of such processing techniques on the activity of bioactive compounds in potatoes.  
Reports from our lab suggest that when compared with raw samples, depending on the 
potato variety, baking decreased or increased the phenolic content (Madiwale, Reddivari et al. 
2012). Purple-fleshed clones CO97215-2P/P and CO97227-2P/PW showed increased phenolic 
content post-baking, whereas phenolic content decreased in white- and yellow-fleshed cultivars 
(Madiwale, Reddivari et al. 2012). Researchers have reported both an increase and a decrease in 
the phenolic content post-baking (Im, Suh et al. 2008, Xu, Li et al. 2009, Blessington, Nzaramba 
et al. 2010, Navarre, Shakya et al. 2010). The increase in the phenolic content post-baking could 
be due to release of bound phenolic compounds during baking. Cooking may weaken the matrix 
thus, improving the extractability of phenolic compounds and inactivate enzymes that use 
phenolic compounds as substrate (Ezekiel, Singh et al. 2011). However, effects of processing 
cannot be generalized for all potato clones as results differ depending on potato genotype – this 
could be due to the differential content of free vs bound phenolic compounds in different 
varieties. Thus, both genotype and processing affect the bioactive content of potatoes (Madiwale 
2012). Among different processing methods, chipping/slicing increases the surface area, thus 
there is greater degradation of bioactive compounds compared to baked and raw samples 





Processing of potatoes also affects the content and composition of other bioactive 
compounds in the potato including vitamin C, glycoalkaloids, acrylamide and resistant starch. 
Effects of processing on the potato toxicants (glycoalkaloids and acrylamide) and resistant starch 
are reviewed in the earlier section. In vitro data from our lab showed that ethanolic extracts of 
raw, baked and chipped purple-fleshed potatoes suppressed proliferation and elevated apoptosis 
in HCT-116 human colon cancer cell line. Anti-proliferative and pro-apoptotic properties of 
baked potatoes were similar to that of raw potatoes, while chipping caused a significant 
reduction in the biological activity (Madiwale 2012). However, there is a dearth of data on health 
benefits of potato bioactive compounds, especially after processing in vivo. It is important to 
document, using appropriate in vivo models, if processed (raw vs. baked vs. chips) anthocyanin-
rich purple-fleshed potatoes retain their anti-oxidant and anti-inflammatory properties in vivo, as 
this aspect has received little consideration. 
 
2.10 Pig as a Model 
There are major drawbacks to the use of rodents or cats/dogs as models for the study of 
human ingestive behavior. In addition to the anatomical and physiological differences between 
rodents and humans, rats and mice were originally granivores. Dogs and cats are carnivores 
whose natural diet and meal patterns differ from those of humans. The expense and scarcity of 
primates have limited their use in studies on food intake (Houpt, Houpt et al. 1979). Thus, the 
pig is an excellent model for studies of nutrition and food intake in humans. An ideal model of 
the human gastrointestinal tract should faithfully replicate the ecology of the gut. Such a model 
would be susceptible to diseases affecting humans, develop similar symptoms, mimic the adults 





model used in the study fulfills several criteria; specifically it is experimentally tractable and it is 
a clinically relevant model of the human gastrointestinal tract (Houpt, Houpt et al. 1979, Cooper, 
Berry et al. 1997, Pond and Lei 2000). 
 
2.11 Aim 2 
Determine Extent to Which Purple-Fleshed Potato Consumption, Even After Processing, 
Prevents or Reverses HFD Elevated Oxidative Stress, and Inflammation Markers in a Pig 
Model.  
 
Approach: We performed two studies – a prevention study where 64 pigs, 3 weeks post-
weaning, consumed one of the eight diets: standard diet (SD), HFD and HFD supplemented with 
raw, baked or chipped purple or white-fleshed potatoes (10 % w/w) for 13 weeks; and a reversal 
study where pigs (12 weeks on HFD after 3 weeks post weaning) consumed HFD containing 10 
or 20 % purple or white-fleshed potato chips for additional 5 weeks (n = 8). Experiment design is 
presented in Figure 2.1. Distal colon mucosa, mesenteric fat, serum, and urine were assayed for 
oxidative stress and inflammatory markers. The pig with nutrient metabolism and gut structure 
anatomically and physiologically similar to humans than any other non-primate mammal was an 










Figure 2.1 Experiment design for the prevention and the reversal studies involving high-fat diet 
consuming pig model. C1, standard control, C & C2, high-fat diet control in reversal and 
prevention studies, respectively, letters P and W indicate purple and white-fleshed potato diets, 
R, B & C indicate processing treatments raw, baked and chips, respectively in the prevention 
study at 10 % supplementation. The numbers 10 and 20 in the reversal study experimental diets 
indicate 10 and 20 % potato supplementation in the diet (chips, w/w).  
 
Providing answers to the in vivo stability and bioactivity of phenolic acids, anthocyanins 
and other bioactive compounds in the purple-fleshed potato, post processing will assist producers 
and consumers to make a more informed decision on shifting production to color-fleshed 
potatoes and determine purchasing preferences, respectively. In addition, understanding the anti-
oxidant and anti-inflammatory effects of potato consumption in a human relevant pig model will 
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RESVERATROL POTENTIATES GRAPE SEED EXTRACT INDUCED HUMAN COLON 




Colon cancer is the third leading cause of cancer deaths in men and women. We and 
others have reported grape seed extract (GSE) and resveratrol (RSV) are potent chemopreventive 
agents against colon cancer both in vitro and in vivo, however, these compounds work in the 
colon only at relatively high concentrations. Since, phytonutrients occur as complex mixtures in 
fruits and vegetables and may work together to modulate their cancer preventive/protective 
properties; we hypothesized that RSV and GSE may act in concert with each other in 
potentiating their anti-cancer properties in vitro at sub-optimal doses. In this study, we showed 
that sub-optimal doses of RSV (~25 µM) potentiated GSE (≤ 35 µg/ml) chemoprotective effects 
via suppressing colon cancer cell proliferation and elevating apoptosis via activation of p53 
dependent pathways. Elevation of apoptosis was more pronounced in p53 +/+ cells compared to 
p53 -/- cells. Apoptosis strongly correlated with phosphorylated p53 (serine 15) levels and 
Bax:Bcl-2 ratio, key players in the mitochondrial apoptotic pathway. Inhibitors of caspase-3 and 
anti-oxidants (quenching free radicals) attenuated apoptosis induced by the combination. RSV-
GSE combination suppressed proliferation and induced apoptosis of HCT-116 colon cancer cells 
in the presence of mitogenic growth factor IGF-1, but did not suppress proliferation or induce 





cells. These observations suggest that RSV-GSE combination and other such naturally occurring 
phytonutrients need to be studied and assessed in combination as they would occur in nature, 
rather than individually.  
 
3.2 Introduction 
In 2009, the American Cancer Society estimated there were more than 100,000 new cases 
and over 40,000 deaths occurred due to colon cancer alone in the US (American Cancer Society 
2009). Since colon cancer has a long latency period before it is detected even in its pre-clinical 
stage (such as colon polyp) (Grady and Carethers 2008), an opportunity exists to institute 
appropriate dietary preventive strategies to halt its progression. Dietary bioactive phytochemicals 
with chemopreventive properties that occur in nature  as complex mixtures in fruits, vegetables, 
grains and herbs, are particularly suited for this purpose (Liu 2004). However, little information 
is available on additive, synergistic or antagonistic interactions among these phytochemicals. 
Resveratrol (RSV), grape seed extract (GSE) and their combination(s) are marketed as popular 
dietary supplements. Independently, RSV and GSE showed anti-cancer activity both in vitro and 
in vivo. But, no studies have been performed or reported on their possible additive or synergistic 
chemoprevention/protective effects.   
Vitis vinifera (Grape vine) is a rich source of several bioactive compounds including 
anthocyanins, flavonoids, polyphenols, proanthocyanidins, and stilbenes (Nassiri-Asl and 
Hosseinzadeh 2009). GSE, a mixture containing about 95% standardized proanthocyanidins, is a 
popular dietary supplement due to its anti-cancer and anti-inflammatory properties (Agarwal et 
al. 2002). In vitro studies showed that GSE has significant growth inhibitory action on a variety 





inhibited cell viability and elevated apoptosis in cancer cells without altering the viability of  the 
normal colon cell lines, thus selectively targeting cancer cells (Laurent et al. 2004). GSE induced 
G1 phase arrest and caspase-3 mediated apoptosis in cancer cells (Laurent et al. 2004; Sharma et 
al. 2004; Kaur et al. 2006). GSE might thus exert its beneficial effects by elevating apoptosis and 
suppressing proliferative pathways. Even though GSE is available through different vendors, 
researchers have reported that regardless of the commercial source, GSE can produce 
comparable biological effects via cell growth suppression in a panel of human colon cancer cell 
lines (Kaur et al. 2008).  
It is well known that GSE typically lacks RSV, except in special preparations, where 
RSV is added back in (Khanna et al. 2001). RSV, a stilbenoid derived from the skin of red 
grapes, has been shown to be active against various cancers in vitro and in vivo (Asensi et al. 
2002; Bhat and Pezzuto 2002; Sexton et al. 2006; Alkhalaf 2007). RSV interferes with all three 
stages of carcinogenesis: initiation, promotion and progression (Jang et al. 1997; Jang and 
Pezzuto 1999; Aziz et al. 2003). We have previously shown that RSV has anti-proliferative and 
pro-apoptotic properties against HT-29 and SW480 human colon cancer cell lines even in the 
presence of mitogenic insulin like growth factor-1 (IGF-1) by elevating phosphorylated p53 (ser 
15) and suppressing IGF-1R/Wnt signaling (Vanamala et al. 2010). However, RSV was effective 
at relatively high concentrations in in vitro studies (RSV > 25-100 µM in different cell lines). 
Though in an occasional instance, RSV was found to be active at low concentrations in vitro 
(Hope et al. 2008). In view of these evidences, we opined that addition of RSV at relatively low 
concentrations (~ 25 μM) to a natural food supplement such as GSE might potentiate the 





matrix in the form of mixtures. Furthermore, the inhibitory efficacy of such a RSV-GSE 
combination on colon carcinogenesis has not yet been reported. 
Insulin like growth factor-1 (IGF-1) is a growth factor and the IGF axis is frequently 
activated during obesity and thus, could play a critical role in obesity-promoted colon cancer 
(Ma et al. 1999; LeRoith and Roberts 2003; Wei et al. 2005). The IGF system includes ligands, 
receptors, and ligand-binding proteins (IGFBPs). Positive energy balance and chronic 
hyperinsulinemia observed in obese conditions may deregulate colonocyte growth kinetics, as 
elevated insulin and suppressed IGFBP-1 and IGFBP-2 levels increase the pool of free or 
bioavailable IGF-1. A larger concentration of bioavailable IGF-1 can activate the IGF-1 receptor 
(IGF-1R is over expressed in colon cancer cells), and stimulate colonocyte proliferation (LeRoith 
and Roberts 2003; Frystyk 2004; Davies et al. 2006; Ahmed et al. 2007; Vanamala et al. 2008). 
Previously, we showed that RSV suppressed IGF-1R protein levels in vitro in human colon 
cancer cells (Vanamala et al. 2010).   
Chemotherapeutic combination approaches have been used to reduce drug toxicity and  
obtain greater efficacy compared to a single active component (Yang and Liu 2009). In a similar 
fashion, the phytochemicals in fruits could be used in combination as anti-cancer agents. 
However, there is little or no evidence for synergistic, additive, or antagonistic effects of grape 
compounds in combination against human colon cancer cells. We hypothesized that RSV and 
GSE work synergistically to suppress colon cancer cell proliferation, at least, in part by inducing 
apoptosis via p53 dependent mechanisms. P53, a critical tumor suppressor gene, is frequently 
deregulated in many cancers and is activated upon DNA damage (Galluzzi et al. 2008). Even 
though GSE induced apoptosis in a p53 dependent manner in skin cancer fibroblasts (Roy et al. 





the present study suggest that RSV potentiates the anti-proliferative and pro-apoptotic properties 
of GSE in a p53-dependent manner. However, this combination induced apoptosis in p53 -/- 
cells, but to a lesser extent. Apoptosis was elevated via p53 activation, and Bax/Bcl-2/ROS and 
caspase-3 pathways. Even in the presence of IGF-1, a mitogenic growth factor elevated during 
obesity, RSV-GSE combination suppressed proliferation and induced apoptosis in HCT-116 p53 
+/+ cells. The promising in vitro results of the RSV-GSE combination in inducing apoptosis of 
colon cancer cells in a synergistic manner, via p53-dependent pathways, even in the presence of 
IGF-1, implies that this combination has therapeutic potential and warrants further investigation 
using in vivo studies. 
 
3.3 Materials and Methods 
3.3.1 Chemicals   
Grape seed extract (GSE, ORAC value 9000-13000 µmole Trolox equivalents/g, total 
phenolic content > 85% gallic acid equivalents was a generous gift from San Joaquin Valley 
Concentrates (Fresno, CA). It is important to note that GSE has been shown to produce 
comparable biological actions irrespective of its commercial source (Kaur et al. 2008). GSE is a 
mixture of mainly dimers, trimers and other oligomers of catechin and epicatechin and their 
gallate derivatives. UPLC-MS analysis of GSE used in the study detected presence of catechin 
and epicatechin monomers and their oligomers, and their gallate derivatives indicating that GSE 
had a similar profile as used in earlier studies ((Agarwal et al. 2007; Weber et al. 2007), Figure 
3.1). We know that GSE typically lacks resveratrol (RSV) and UPLC-MS analysis of GSE 





best below 0.016% by mass (value obtained by standard curve) even if we assume 90% 
ionization suppression due to the complex matrix of GSE.   
Fetal bovine serum (FBS) was purchased from Fisher Scientific (Pittsburgh, PA). 
McCoy’s 5A medium (modified, 1X) was purchased from Invitrogen (Carlsbad, CA). The p53 
inhibitor Pifithrin-α, the caspase-8 inhibitor z-IETD-FMK, and the caspase-3 inhibitor z-DEVD-
FMK were purchased from Calbiochem (San Diego, CA). N-acetylcysteine, catalase enzyme, 
Dulbecco’s Modified Eagle’s Medium F-12 (DMEM/F-12), 5-florouracil (5-FU) and RSV were 












Figure 3.1 Representative single ion UPLC-MS chromatograms of catechin and epicatechin 
monomers and their oligomers, and their gallate derivatives present in the grape seed extract 
used in the study prepared at 5 mg/ml in water-methanol mixture. Detailed procedure for LC/MS 
is mentioned in the materials and methods. 
 
3.3.2 LC-MS Analysis of Grape Seed Extract 
GSE was dissolved in water-methanol mixture to attain a concentration of 5 mg/ml. 1 µl 
injections of the solution were performed on a Waters Acquity UPLC system. Separation was 
performed using a Waters Acquity UPLC HSS T3 column (1.8 µM, 1.0 x 100 mm), using a 
gradient from solvent A (Water + 0.1% formic acid) to solvent B (95% methanol, 5% water, 





13 minute linear gradient to 100% B which was held at 100% B for 2 minutes then returned to 
starting conditions over 0.1 minute, and finally allowed to reequilibrate for 2.9 minutes. Flow 
rate was constant at 140 µl/min for the duration of the run. The column was held at 50°C, 
samples were held at 5°C. Column eluent was infused into a Micromass Q-Tof Micro MS fitted 
with an electrospray source. Data was collected in positive ion mode, scanning from 50-1200 at a 
rate of 0.9 scans per second with 0.1 second interscan delay. Calibration was performed prior to 
sample analysis via infusion of sodium formate solution, with mass accuracy within 5 ppm. The 
capillary voltage was held at 2200V, the source temp at 130°C, and the desolvation temperature 
at 300°C at a nitrogen desolvation gas flow rate of 400 l/hr. The quadrupole was held at collision 
energy of 7 volts.   
 
3.3.3 Cell Lines 
The HCT-116 p53 +/+ and p53 -/- colon cancer cell lines were obtained  from Dr. Bert 
Vogelstein (School of Medicine, the Johns Hopkins University, Baltimore, MD, USA). Cells 
were maintained at 37oC with 5% CO2 and grown in McCoy’s 5A medium supplemented with L-
glutamine, 25 mM HEPES buffer, 100 ml/l fetal bovine serum and 10 ml/L Penicillin-
Streptomycin mix. CRL-1831 cells were obtained from American Type Culture Collection 
(Manassas, VA) and were maintained at 37°C with 5% CO2 and grown in Dulbecco's Modified 
Eagle's Medium F-12 (DMEM/F-12) supplemented with 2.2 g/l sodium bicarbonate, 0.2 g/l 
bovine serum albumin, 100 ml/l fetal bovine serum and 10 ml/l Penicillin-Streptomycin mix. 







3.3.4 Cell Proliferation Assay 
Cell viability was assessed by a modified 3-(4, 5-dimethylthiazol-2-yl)-2, 5-
diphenyltetrazolium bromide assay (WST-1 assay; Roche Diagnostics, Indianapolis, IN) 
following the supplier’s protocol. WST-1 assay was used after validating the assay using cell 
counting. Briefly, cells were grown in 96-well plates (5,000 cells/well), overnight at 37°C, in a 
5% CO2 incubator and treated with RSV and/or GSE for indicated time period. After addition of 
WST-1 reagent (1:10 dilution in media), cells were incubated for 3 h and absorbance at 450 nm 
was measured by a micro plate reader. The experiments were repeated three times each time in 
triplicate and data were expressed as the means ± SEs. For experiments using IGF-1, cell 
proliferation was measured via cell counting using Cellometer (Nexcelom Biosciences, 
Lawrence, MA). The experiments were repeated three times each time in triplicate and data were 
expressed as the means ± SEs. 
 
3.3.5 Cytotoxicity Detection 
To validate, if the concentrations of RSV and GSE used in the study are not toxic to the 
cells (induce necrosis), a dose response cytotoxicity detection assay using different 
concentrations of RSV and GSE was done. HCT-116 p53 +/+ and p53 -/- cells (5,000/well) were 
seeded in 96-well plates and after treatment for 24 h, the Cytotoxicity Detection Kit (Roche 
Diagnostics, Indianapolis, IN) was used to measure the Lactate-dehydrogenase (LDH) activity in 
supernatants of cells treated with respective treatments, according to the instruction manual 
protocol. Briefly, after 30 min incubation at 37°C, absorbance was recorded on a micro plate 
reader at 492 nm. The experiments were done in triplicate and repeated at least three times, and 





calculated with the formula: % Cytotoxicity = (experimental value - low control) X 100 / (high 
control - low control), where low control is the assay medium plus cells and high control is the 
assay medium plus 2 % Triton X-100 plus cells. 
 
3.3.6 Apoptosis Assay 
Apoptosis induction was measured using 2 different assays; a nucleosomal fragmentation 
assay (Cell Death Detection Enzyme Linked ImmunoSorbent Assay (ELISA), Roche 
Diagnostics, Indianapolis, IN) followed by confirmation using caspase-3 cleavage (Caspase-
Glo 3/7 assay, Promega, Madison, WI). Briefly, for the nucleosome ELISA assay, 100,000 cells 
were plated per well in 12-well plates, and then treated with the respective treatments. After 12 h 
or 24 h incubation, cells were counted and assayed for apoptosis as per the manufacturer’s 
protocol. Absorbance was recorded on a micro plate reader at 405 nm. The optical density was 
normalized to total number of cells in each treatment. For the caspase-glo 3/7 assay, cells were 
incubated for 12 h or 24 h with respective treatments. After incubation, cells were trypsinized 
and approximately 20,000 cells from each treatment were incubated with 100 µl of caspase-glo 
3/7 reagent for 3 h. The luminescence of each sample was measured using a luminometer. 
DMSO was the solvent control. These experiments were repeated at least twice and each time in 
triplicate and data were expressed as the means ± SEs.   
 
3.3.7 Experimental Design of Combination Study 
A two-way combination of RSV and GSE against HCT-116 p53 +/+ and p53 -/- cell 
proliferation was designed (Yang and Liu 2009). The IC 50 values of RSV and GSE were 





values of RSV and GSE, a series of concentrations were used to select a few combinations that 
might demonstrate synergistic, additive or antagonistic response (C1-C9, Table 3.1).  
The combination effects were analyzed by the combination index (CI) method. The CI is 
based on the classic isobologram equation (Sharma et al. 2004); CI = D1/d1 + D2/d2; where  D1 
and D2 are the doses of RSV and GSE, respectively, in the combination system; d1 and d2 are 
the doses of RSV and GSE alone for the same fractional inhibition, respectively. For data 
analysis of combinations, CI ≤ 1, CI = 1, and CI > 1 indicate synergistic, additive, and 
antagonistic effects, respectively (Sharma et al. 2004; Yang and Liu 2009). C1 and C2 were 
chosen for further experiments based on low concentrations of RSV (~ 25 µM) and its ability to 
induce apoptosis comparable to high doses of RSV and GSE (100 µM or 100 µg/ml) in HCT-116 






Figure 3.2 Anti-proliferative, cytotoxic and apoptotic effects of resveratrol (RSV) and grape 
seed extract (GSE). (A) RSV and (B) GSE suppressed HCT-116 colon cancer cell proliferation 
and (C) induced apoptosis but do not show any (D) cytotoxic effects. HCT-116 p53 +/+ and -/- 
cells were treated with RSV (25, 50, 75, and 100 µM) or GSE (25, 37.5, 50, 75 and 100 μg/ml) 
for 48 h and cell proliferation was determined using WST-1 assay and cytotoxicity was detected 
in the supernatants using LDH assay. HCT-116 p53 +/+ and -/- cells were treated with RSV (25, 
50, 75 and 100 µM) or GSE (37.5, 50, 75 and 100 μg/ml) for 12 h and induction of apoptosis was 
determined by cell death detection ELISA assay. The rate of apoptosis was expressed as 
absorbance value measured at 405 nm. Results were expressed as mean ± SE for three replicate 





as a positive control for LDH assay. Means that differ by a common letter (a, b, c, d, e, f, g for 







Table 3.1 Combination index (CI) analysis of HCT-116 p53 +/+ and p53 -/- cells treated with different combinations of resveratrol 
(RSV) and grape seed extract (GSE). HCT-116 p53 +/+ and -/- cells were treated with combination of GSE and RSV at different 
concentrations for 48 h and cell proliferation was determined using WST-1 assay and apoptosis (24 h, only in p53 +/+ cells) was 
measured using caspase-glo 3/7 assay. Fractional inhibition was calculated as a percentage with respect to control and CI values were 
calculated based on method of Chou and Talalay (Chou and Talalay 1983). C1 and C2 (in bold) were chosen for further experiments 
based on low concentrations of RSV (~ 25 µM) and its ability to induce apoptosis comparable to high doses of RSV and GSE (100 
µM or 100 µg/ml) in HCT-116 p53 +/+ colon cancer cells. 
Treatment P53 +/+ cells P53 -/- cells 
Combinations RSV (µM) GSE (µg/ml) Fractional inhibition (%) CI value 
Apoptosis (X 100 
Lumens) 
Fractional inhibition (%) CI value 
C1 27 35.2 70.17 0.668 201.7 74.16 0.687 
C2 23.59 50.93 79.03 0.812 245.0 75.17 0.858 
C3 15.73 33.95 70.05 0.561 129.4 72.47 0.608 
C4 23.6 30 59.82 0.61 139.7 59.95 0.792 
C5 31.45 67.9 81.64 1.078 383.4 80.36 1.008 






C7 41.25 24.75 48.24 0.755 99.1 66.86 0.753 
C8 45 58.75 83.93 1.09 317.0 77.43 1.067 





3.3.8 Fluorescence Activated Cell Sorting Analysis (FACS) 
HCT-116 p53 +/+ and p53 -/- cells were plated at a density of 15 × 106 cells per 100 mm 
plate and after 24 h treatment with either the control or the RSV-GSE combinations, cells were 
trypsinized and centrifuged. The pellet was resuspended with 1 ml of PI staining buffer 
containing 4 mM sodium citrate, 0.1% Triton X-100, 50 μg/ml propidium iodide and 200 μg/ml 
RNAse and incubated for 10 minutes at 37°C in the dark, and the final concentration of sodium 
chloride was adjusted to 0.15 M. Cells were analyzed using MoFlo (Dako Colorado, Inc.) flow 
cytometer and high speed cell sorter. Results were reported as percent cells in each phase of the 
cell cycle. 
 
3.3.9 Western Blot Analysis 
HCT-116 p53 +/+ and p53 -/- cells were seeded at a density of 1.5 x 105 cells/ml in 
DMEM F-12 media with 5% charcoal-stripped fetal bovine serum for 24 h. After treating cells 
for 24 h, protein was extracted into a high-salt buffer containing 1% protease and phosphatase 
inhibitor cocktail from Thermo Scientific (Rockford, IL), and protein concentrations were 
determined by using the BCA Protein Assay kit from Thermo Scientific (Rockford, IL). Cell 
lysates (45 g) were incubated at 98oC for 5 minutes and separated by 10% polyacrylamide gels 
running at 120 V for 2 h in 1X running buffer, and electrophoretically transferred to Immobilon-
FL, low fluorescent PVDF membranes from Millipore (Billerica, MA) at 30 V for 98 min in 
Tris-glycine transfer buffer. The membranes were blocked with Superblock blocking buffer from 
Thermo Scientific (Rockford, IL) for 2 h at room temperature. The membranes were incubated 
with rabbit polyclonal anti-pp53 antibody, rabbit polyclonal anti-Bax antibody, both from Cell 





both from Santa Cruz Biotechnology (1:500 for Bcl-2, 1: 5000 for β-actin; Santa Cruz, CA) for 2 
h at room temperature. Membranes were subsequently probed with anti-goat or anti-rabbit IR 
Dye secondary antibodies, Licor Biosciences (all 1:10,000, Lincoln, NE). Membranes were 
scanned and quantified with Odyssey infrared imaging system, Licor Biosciences (Lincoln, NE) 
using Odyssey software (Licor Biosciences). Membranes were also probed with respective IgG-
HRP secondary antibodies from Santa Cruz Biotechnology (1:20,000; Santa Cruz, CA) and 
scanned using UVP imaging software (UVP BioDoc-It® Imaging System; Upland, CA). β-actin 
served as a loading control.  
 
3.3.10 IGF-1 Treatment 
Cells were plated at a density of 5 X 104 per well in 12-well plates in DMEM/F-12 
containing 5% charcoal-stripped fetal bovine serum. After 24 h, cells were treated with DMSO 
(solvent control), 25 nM IGF-1 and/or combinations of RSV and GSE (C1 and C2), and anti-
proliferative properties of the RSV-GSE combinations were evaluated after 48 h. As colonocytes 
have greater exposure to the bioavailable IGF-1 in obese condition, in the IGF-1 treatments, the 
cells were pre-incubated with IGF-1 for 10 minutes followed by the combination treatment to 
assess the effect of RSV-GSE combination when the cells are already primed to proliferate. Dose 
response study showed that 25 nM IGF-1 is essential to produce a significant elevation of HCT-
116 p53+/+ cell proliferation (data not shown). In case of  HT-29 and SW-480 advanced colon 
cancer cell lines, even 10 nM IGF-1 was sufficient to prime the cells to proliferate (Vanamala et 
al. 2010). Thus, we used 25 nM concentration of IGF-1 for subsequent experiments in HCT-116 





manufacturer’s protocol using the cell death detection ELISA kit using the manufacturer’s 
protocol. 
 
3.3.11 Statistical Analysis 
Analysis of variance and Fisher’s least square difference at 5 % significance level 
determined degree of significance between treatments. Pearson correlation at 1 % determined 
correlation between apoptosis and Bax/Bcl-2 ratio.  
 
3.4 Results 
3.4.1 Resveratrol (RSV) or Grape Seed Extract (GSE) Suppressed Cell Proliferation of 
HCT-116 Cells 
Anti-proliferative and cytotoxic effects of RSV or GSE were investigated using HCT-116 
p53 +/+ and p53 -/- colon cancer cells. RSV or GSE resulted in suppression of cell proliferation 
in a dose dependent manner (Figure 3.2A, 3.2B). Our results demonstrated that RSV suppresses 
the colon cancer cell proliferation in both p53 +/+ and p53 -/- cells (Figure 3.2A), however, cell 
proliferation suppression was more potent in p53 -/- cells (IC 50 of RSV was 72 M in p53 -/- 
cells compared to 110 M in p53 +/+ cells). Treatment of HCT-116 p53 +/+ cells with 37.5, 50, 
75, 100 and 125 g/ml of GSE resulted in 31-90% cell proliferation suppression (Figure 3.2B). 
Similar growth inhibition was seen in p53 -/- cells, however the IC 50 for GSE was higher in p53 
-/- cells (47 g/ml compared to 37.5 g/ml in p53 +/+ cells). Together, the data in Figures 3.2A 
and 3.2B clearly demonstrate the efficacy of RSV or GSE to inhibit the growth of human colon 
cancer cells (HCT-116 p53 +/+ and p53 -/-). The cytotoxicity of RSV or GSE towards HCT-116 





for RSV or GSE even at concentrations up to 100 M and 100 g/ml, respectively (Figure 3.2D). 
Cytotoxicity was compared against the positive control Triton X-100. 
 
3.4.2 RSV or GSE Induced Apoptosis 
Induction of apoptosis by RSV or GSE in HCT-116 p53 +/+ and p53 -/- cells was 
analyzed using nucleosomal fragmentation assay (Cell Death Detection ELISA). RSV induced 
apoptosis in both p53 +/+ and p53 -/- cells, however, only at higher concentrations close to 100 
µM (Figure 3.2C). GSE also induced apoptosis, but mainly in p53 +/+ cells (GSE > 75 µg/ml) 
(Figure 3.2C). This suggests that low concentrations of RSV and GSE, are unable to induce 
apoptosis even though they might be able to suppress cell proliferation (Figure 3.2A, 3.2B and 
3.2C). Confirmation using a p53 inhibitor (Figure 3.4E), suggest that RSV induced apoptosis in a 
p53-independent manner; however, GSE requires a functional p53 to induce apoptosis in HCT-
116 cells.   
 
3.4.3 RSV-GSE Combination Suppressed Cell Proliferation and Induced Apoptosis.  
Based on the anti-proliferative and pro-apoptotic properties of RSV or GSE in the HCT-
116 cell lines, the effect of the combination of RSV and GSE on the HCT-116 p53 +/+ and p53 -
/- cells was analyzed. Possible combinatorial effects (synergy, additive or antagonism) were 
assessed using a series of nine different combinations (Table 3.1). Data were analyzed using 
combination index (CI) values by the method of Chou and Talalay (Chou and Talalay 1983). 
Results indicated that a combination of RSV and GSE resulted in a greater growth inhibition as 
compared to either agents alone at the same concentrations (Table 3.1, Figure 3.2A and 3.2B) in 





showed synergism, whereas the other two showed additive effects in p53 +/+ cells (Table 3.1). 
Elevated cell proliferation suppression was seen in p53 -/- cells, wherein the same seven 
combinations demonstrated synergism as in p53 +/+ cells (Table 3.1). For the nine combinations, 
apoptosis was measured, albeit only in p53 +/+ cells. Out of the nine combinations, two 
combinations (C1: RSV 27 µM and GSE 35 µg/ml and C2: RSV 25 µM and GSE 51 µg/ml) 
were selected for further experiments based on their ability to adequately suppress cell 
proliferation, induce apoptosis comparable to RSV doses of 100 µM, low CI values and reduced 
RSV levels. Low doses of RSV and GSE in combinations C1 and C2 are unable to elicit 
apoptosis individually in p53 +/+ cells (Figure 3.2C). 
 
3.4.4 RSV-GSE Combination Induced Cell Cycle Arrest in Go/G1 Phase in Both HCT 116 
P53 +/+ and P53 -/- Cells 
Fluorescence-activated cell sorting analysis (FACS) technique was used to determine the 
effect of RSV-GSE combination on cell cycle progression in HCT-116 cells. Figures 3.3A and 
3.3B illustrate the distribution of HCT-116 p53 +/+ cells and p53 -/- cells in the G0/G1, S and 
G2/M phases after treatment with the RSV-GSE combination, respectively. RSV-GSE 
combination had higher percentage of cells in the G0/G1 phase compared to control in both p53 
+/+ and p53 -/- cells. These results suggest that the RSV-GSE combination targets G0/G1 to S 







Figure 3.3 Effect of combination of resveratrol (RSV) and grape seed extract (GSE) on cell 
cycle progression of HCT 116 colon cancer cells. HCT-116 p53 +/+ (A) and p53 -/- (B) cells 
were plated at a density of 15 × 106 cells per 100 mm plate and after 18 h treatment with the 
vehicle (DMSO), C1 and C2; they were analyzed by fluorescence-activated cell sorting analysis 
(FACS). Results were expressed as % of cells in each phase. Numbers on top of the bars 
represent percent cells in respective phases in each treatment group. C1 and C2 have RSV (27 
µM and 25 µM) and GSE (35 and 51 µg/ml), respectively.  
 
3.4.5 RSV-GSE Combination Induced Apoptosis is P53-Dependent 
We used nucleosomal fragmentation assay and caspase-glo 3/7 assay to detect whether 
combination of RSV and GSE induces apoptotic death. There was an increase in apoptosis with 
the two combination doses (C1 and C2) compared to the control (Figure 3.4A). This is 
particularly important, since RSV (~ 25 µM) or GSE (~ 37.5 µg/ml) alone do not induce 
apoptosis at the concentrations present in the combination (Figure 3.2C and Table 3.1). Similar 
results were obtained when apoptosis was measured using the caspase-glo 3/7 assay confirming 





RSV or GSE alone at high concentrations demonstrated p53 independent and p53 
dependent apoptosis respectively, at 24 h time point (Figure 3.2C), however, at the low 
concentrations used in C1 or C2 neither RSV nor GSE induced apoptosis in p53 +/+ or p53 -/- 
cells. However, we did see a difference in the induction of apoptosis by RSV-GSE combination 
in p53 +/+ and p53 -/- cells at 12 h (Figure 3.4A and 3.4B). To confirm, if p53 plays an 
important role in apoptosis induction by the RSV-GSE combination, cells were treated with RSV 
and/or GSE for a further 12 h (total 24 h). After 24 h, significant differences were observed 
between p53+/+ and p53-/- cells in the induction of apoptosis with RSV-GSE combination, 
suggesting that combination treatment requires a functional p53 to induce apoptosis (Figure 
3.4B). Results were confirmed using caspase-glo 3/7 assay (Figure 3.4D). However, increasing 
GSE concentration to 50 µg/ml did not elevate apoptosis in C2 compared to C1 indicating that 
once GSE levels reach 50 µg/ml, RSV had a marginal effect to potentiate GSE actions. This also 
suggests that the effect of synergy is at best when the two compounds are at low concentrations 
together.  
To confirm the role of p53, transcriptional activity of p53 was inhibited using the p53 
inhibitor pifithrin-α (40 µM, (Murphy et al. 2004)) and then treated with the combination 
treatment for 24 h and assayed for apoptosis. HCT-116 p53 +/+ cells treated with the p53 
inhibitor acted like the p53 -/- cells, and the RSV-GSE combination did not induce apoptosis in 
p53 +/+ cells in the presence of the p53 inhibitor (Figure 3.4E). This confirms that the RSV-GSE 
combination induced apoptosis via p53 related signaling pathways. Further experiments 







Figure 3.4 Synergistic combination of resveratrol (RSV) and grape seed extract (GSE) induced 





treated with RSV and/or GSE for 12 and 24 h and induction of apoptosis was determined by cell 
death detection ELISA assay. The rate of apoptosis was expressed as absorbance value measured 
at 405 nm, normalized to 106 cells. (B, D) HCT-116 p53 +/+ and -/- cells were treated with RSV 
and GSE alone and in combination for 12 and 24 h and apoptosis was determined using caspase-
glo 3/7 assay. E) HCT-116 p53 +/+ cells were pretreated with the p53 inhibitor pifithrin-α (40 
µM) for 45 minutes followed by RSV and/or GSE for 24 h and apoptosis was detected using 
caspase-glo 3/7 assay. Results were expressed as mean ± SE for three replicate experiments for 
each treatment group. C1 and C2 have RSV (27 µM and 25 µM) and GSE (35 and 51 µg/ml), 
respectively.  Means that differ by a common letter (a, b, c, d, e for p53 +/+ cells and w, x, y, z 
for p53 -/- cells or pifithrin-α treatment) differ (P ≤ 0.05).  
 
3.4.6 RSV-GSE Combination Suppressed Cell Proliferation and Induced Apoptosis via 
Caspase-3 Dependent and Bax/Bcl-2 Pathways. 
To investigate whether the induction of apoptosis by RSV-GSE combination in HCT-116 
p53 +/+ cells was through activation of p53 downstream pathways, lysates from cells treated 
with RSV and GSE, alone and in combination, were subjected to western blot analysis. RSV in 
combination with GSE elevated pp53 (activated p53, ser 15) in HCT-116 p53 +/+ cell lines 
(Figure 3.5A). This is particularly interesting because RSV or GSE were not as effective in 
elevating pp53 levels at lower concentrations present in the combination (Figure 3.5A). Levels of 
Bax and Bcl-2, pro and anti-apoptotic members of the BH3 family of apoptotic proteins were 
measured in the combination treatment in p53 +/+ cells. Combination of RSV and GSE elevated 
Bax levels and concomitantly suppressed levels of Bcl-2, overall elevating the Bax:Bcl-2 ratio 





(Pearson correlation coefficient = 0.878 for p53 +/+ cells, P ≤ 0.01), indicating the RSV-GSE 
induced apoptosis might be via the mitochondrial mediated apoptotic pathway (De Angelis et al. 
1998).  
To further confirm the route of apoptosis, caspase-3 and caspase-8 were inhibited 
separately and then treated with the combination treatment. We measured apoptosis using the 
nucleosomal fragmentation assay 24 h post treatment. Treatment with the cell-permeable 
caspase-3 inhibitor DEVD-CHO (50 µM) suppressed RSV-GSE combination induced apoptosis 
(Figure 3.5C). In contrast, incubation with the caspase-8 inhibitor IETH-CHO (50 µM) had no 
significant effect on apoptosis induction by RSV-GSE combination, indicating that the cell death 
is not through the death receptor-mediated pathway involving caspase-8 activation (Figure 3.5C). 













Figure 3.5 Apoptotic induction by the synergistic combination of resveratrol (RSV) and grape 
seed extract (GSE) involves pathways downstream of p53. HCT-116 p53 +/+ and p53 -/- cells 





and 25 µM) and GSE (35 and 51 µg/ml), respectively. Whole cell lysates were analyzed by 
western blotting for (A) pp53, (B) Bax, Bcl-2 as described in materials and methods. Blots were 
incubated with the indicated antibodies. Similar results were obtained in duplicate experiments. 
(C) HCT-116 p53 +/+ cells were treated with cell permeable caspase-3 (50 µM) and caspase-8 
(50 µM) inhibitors for 45 minutes followed by RSV and/or GSE and apoptosis was detected 
using cell death detection ELISA assay. 5-florouracil (5-FU) served as the positive control. RSV 
100 and GSE 100 also served as positive control based on earlier reports (Park et al. 2001; Roy 
et al. 2005). Results were expressed as mean ± SE for three replicate experiments for each 
treatment group. * indicates significant suppression compared to control (no inhibitor). Means 
that differ by a common letter (a, b, c, d) differ (P ≤ 0.05).  
 
3.4.7 N-Acetyl Cysteine (NAC) Inhibited RSV-GSE Combination Induced Apoptosis in 
HCT-116 P53 +/+ Cells  
 HCT-116 p53 +/+ cells were pre-incubated with NAC (2 mM), a free radical scavenger 
and/or catalase (CAT; 100 U/ml), a hydrogen peroxide radical scavenger, for 1 h and then treated 
with RSV-GSE combination for a total time of 24 h. Both proliferation and apoptosis were 
measured using WST-1 and caspase-glo 3/7 assays, respectively. In the presence of NAC, RSV-
GSE combination induced proliferation arrest, however apoptosis was suppressed. However, 
CAT could suppress neither proliferation arrest nor apoptosis induced by the combination 








3.4.8 RSV-GSE Combination is Non-Toxic to Normal Cells 
 To know the effect of RSV-GSE combination on normal cells, CRL-1831 normal colon 
epithelial cells were treated with the RSV-GSE combination for 24 h and assessed for 
proliferation and apoptosis using WST-1 and caspase-glo 3/7 assays, respectively. RSV-GSE 
combination induced neither proliferation arrest nor apoptosis elevation suggesting that the 
combination is effective against cancer cells with no adverse action on normal cells (Figure 3.6C, 



















Figure 3.6 N-acetyl cysteine (NAC) suppresses resveratrol (RSV)-grape seed extract (GSE) 
combination’s anti-proliferative (A) and pro-apoptotic (B) properties. HCT 116 p53+/+ and p53 -





to the RSV-GSE combination (24 h treatment in total) and assessed for proliferation and 
apoptosis using WST-1 and caspase-glo 3/7 assay respectively. C-F: RSV-GSE combination is 
non-toxic to normal cells, but showed anti-proliferative and pro-apoptotic properties even in the 
presence of insulin like growth factor-1 (IGF-1) in HCT-116 cells. CRL-1831 normal colonic 
epithelial cells were treated with RSV, GSE alone and in combination and proliferation (48 h) 
(C) and apoptosis (24 h, D) were measured by WST-1 and caspase-glo 3/7 assay respectively. 
HCT-116 p53 +/+ cells were primed to proliferate by incubation with IGF-1 (25 nM) for 10 
minutes followed by RSV and/or GSE. Cell proliferation (E) was measured using WST-1 assay 
48 h after treatment. For apoptosis (F), cells were seeded in 12 well plates pre-treated with IGF-1 
(25 nM) followed by treatment with RSV and/or GSE and apoptosis was measured using cell 
death detection ELISA assay 24 h post treatment. Results were expressed as mean ± SE for three 
replicate experiments for each treatment group. C1 and C2 have RSV (27 µM and 25 µM) and 
GSE (35 and 51 µg/ml), respectively. Means that differ by a common letter (a, b, c, d, e, f for 
p53 +/+ cells and w, x, y, z for IGF-1 treatments) differ (P ≤ 0.05).  
 
3.4.9 RSV-GSE Combination Suppressed Cell Proliferation and Induced Apoptosis Even in 
the Presence Of IGF-1 
Growth stimulatory effects of IGF-1 and the anti-proliferative effects of RSV-GSE 
combinations were investigated using HCT-116 p53 +/+ cells. Our results demonstrated that 
RSV-GSE combinations suppressed colon cancer cell proliferation even when the cells were 
primed to proliferate with IGF-1. After 48 h, IGF-1 (25 nM) treatment elevated HCT-116 cell 
proliferation confirming its growth stimulatory effects (Figure 3.6E). Moreover, pre-incubation 





suppressed cell proliferation (Figure 3.6E). Induction of apoptosis by the RSV-GSE combination 
in the presence of IGF-1 was analyzed using nucleosomal fragmentation assay. The combination 
treatment induced apoptosis even in the presence of IGF-1 suggesting its role as a potential 
chemopreventive agent even against IGF-1-promoted colon cancers (Figure 3.6F). 
 
3.5 Discussion 
Current strategy of cancer management includes: surgery, radiation therapy and 
chemotherapy, and in occasional instances investigational drug use on a case by case basis. 
However, conventional therapy is associated with many side-effects. Hence, methods are 
designed to improve the efficacy of these treatment modalities or to devise newer ways to treat or 
even prevent cancer are needed. However, most chemoprevention trials with single active 
compounds fail to provide satisfactory results. Epidemiological studies showed that plant based 
diets are associated with reduced risk of developing chronic diseases, such as cancer and 
cardiovascular disease (Liu 2004). Phytochemicals possess potent antioxidant and anti-
proliferative properties (Liu 2003). We previously showed that RSV at concentrations  > 100 µM 
suppressed colon cancer proliferation even in the presence of IGF-1, a mitogenic growth factor, 
by  inhibiting the critical components in the IGF-1R/Wnt signaling pathway, and elevated 
apoptosis (Vanamala et al. 2010). However, in fruits and vegetables, bioactive compounds exist 
as a complex mixture that synergize or complement each other’s chemopreventive/protective 
actions. The results of the present study are in support of such belief since the present study 
showed that suppression of proliferation and elevation of apoptosis in HCT-116 p53 +/+ human 
colon cancer cell lines at 100 µM or higher concentrations of RSV could be accomplished at 25 





support our hypothesis that combining bioactive compounds like RSV and GSE could reduce the 
dose of either compound while providing similar or better anti-cancer properties in vitro lending 
support to the proposal that combinatorial approach towards colon cancer chemoprevention is a 
feasible approach. RSV and GSE induced apoptosis in a variety of cancer cell lines (Jang et al. 
1997; Agarwal et al. 2002; Banerjee et al. 2002; Bhat and Pezzuto 2002; Laurent et al. 2004; 
Sharma et al. 2004; Kaur et al. 2006; Sexton et al. 2006; Alkhalaf 2007; Engelbrecht et al. 2007; 
Kaur et al. 2008; Athar et al. 2009; Vanamala et al. 2010). Even though synergistic combination 
treatments enhanced apoptosis in both HCT-116 p53 +/+ and p53 -/- cells, at 12 h post treatment, 
apoptosis was more pronounced in p53 +/+ cells compared to p53 -/- cells, suggesting a 
significant role for p53. At 24 h post treatment, both the combinations induced apoptosis only in 
p53 +/+ cells. Involvement of p53 in the enhancement of apoptosis in HCT-116 p53 +/+ by 
RSV-GSE combination was reaffirmed by the use of p53 transcriptional inhibitor pifithrin-α, that 
is known to block p53-dependent transcriptional activation and apoptosis.  
RSV and GSE demonstrated p53 independent and p53 dependent apoptosis alone at high 
concentrations at 24 h time point (Figure 3.2C). RSV when used at > 100 µM effectively 
suppressed proliferation and augmented apoptosis in comparison to the action of GSE when used 
alone or in combination with RSV in HCT-116 p53 -/- cells. These results indicate that RSV at 
higher concentrations works via p53 independent pathways to suppress cell proliferation and 
induce apoptosis. However, in HCT-116 p53 -/- cells, combination of GSE and RSV did enhance 
apoptosis to a small extent possibly via p53 independent pathways indicating that RSV might 
potentiate apoptotic action of GSE independent of p53 status of the cells. Overall, the results are 
still intriguing since the low concentrations of RSV and GSE in C1 and C2 did not induce 





C2 did not differ significantly in inducing apoptosis indicating that the potentiating effect of 
RSV is marginal once the GSE concentration reaches 50 µg/ml.  
In the present study, RSV-GSE combination induced apoptosis via activating p53 (pp53), 
elevating Bax and suppressing Bcl-2 (increase in the Bax:Bcl-2 ratio) in p53 +/+ cells, which 
alters mitochondrial membrane permeability. Such altered mitochondrial membrane permeability 
releases cytochrome C into the cytosol (Lomonosova and Chinnadurai 2008; Kang and Reynolds 
2009) that triggers activation of caspase-9, which accelerates apoptosis by activating other 
caspases. It is evident from the results of the present study that caspase-3 inhibitor suppressed 
apoptosis induced by the combination of RSV-GSE while caspase-8 inhibitor had no significant 
effect on apoptosis, suggesting that the cell death is not through the major death receptor-







Figure 3.7 Summary of the signaling pathways for resveratrol-grape seed extract (RSV-GSE) 
combination-induced apoptosis. RSV-GSE combination induced apoptosis involves interplay of 
reactive oxygen species (ROS), p53, Bax/Bcl-2 and caspase-3. 
 
Several studies have suggested that cancer chemotherapeutic drugs induce apoptosis of 
tumor cells, in part, by inducing the formation of reactive oxygen species (ROS) (Hou et al. 
2005; Low et al. 2010). The p53 tumor suppressor gene can induce either apoptosis 
or senescence in response to cellular stresses (Shatrov et al. 2000; Macip et al. 2003). ROS 
accumulation and mitochondrial function can contribute to p53-dependent apoptosis and it has 
been shown in multiple studies that ROS inducers like bioactive agents collaborate with p53 to 





2008). Recent articles have pointed out the importance of the Bax, Bcl-2 and ROS production in 
tumor cells (Chen and Pervaiz 2007). Bcl-2 overexpression, in particular, has shown to suppress 
apoptosis induced by RSV by a pathway that involves ROS production (Low et al. 2010). Our 
results indicated that N-acetylcysteine, a free radical scavenger and glutathione precursor, 
suppressed apoptosis induced by the RSV-GSE combination. However, catalase, an anti-oxidant 
enzyme that brings about its cytoprotective action by suppressing or neutralizing the toxic 
hydrogen peroxide radicals, could not inhibit the cytotoxic action of RSV-GSE. These results 
indicate that this combination (RSV-GSE) does not bring about its actions by augmenting 
hydrogen peroxide radical formation (Aragon et al. 1992). Since NAC could protect against the 
combination induced apoptosis, the activation of caspase cascade could be linked to the 
generation of ROS (Hou et al. 2005). Our results explain that the pathway that the combination 
induces apoptosis involves an interplay between ROS, p53, Bax/Bcl-2 and caspase-3 (Figure 3.7) 
(Liu et al. 2008; Low et al. 2010). ROS can act via enhancing mitochondrial membrane 
permeability and thus can induce apoptosis via the caspase-3 cascade (Hou et al. 2005). Overall, 
these results are in support that mitochondrial apoptotic pathway is responsible for the observed 
apoptosis in HCT-116 cells.  
Further, RSV-GSE combination did not suppress the proliferation or induce apoptosis of 
normal colon epithelial cell CRL-1831 line indicating that the RSV-GSE combination 
preferentially target cancer cells while sparing their normal counterparts. The exact reason for 
this is not clear but could be due to differential metabolism of bioactive compounds in normal 






The germline adenomatous polyposis coli mutations in colonocytes are highly predictive 
of colon cancer. Hence, the use of RSV-GSE combination that selectively activates p53 to induce 
apoptosis in colon cancer but not in normal cells could be a promising dietary approach in its 
prevention. This is particularly interesting in the light of the known fact that polyps possess 
intact p53 and colon cancers develop from the polyps. Based on these results, it is important to 
pursue the chemopreventive and chemoprotective properties of RSV-GSE synergistic 
combination in both rodent and human models of colon cancer in future studies.  
Members of IGFs family and the IGF-binding proteins (IGFBPs) play a critical role in the 
progression of a variety of cancers during obesity including colon cancer (Dupont et al. 2003). 
Recently we showed that RSV at ≥ 100 µM concentration could effectively suppress IGF-1 
(elevated during obesity) stimulated growth of human colon cancer cell lines via suppression of 
IGF-1R/PI3K/-catenin pathway. IGF-1 binding to IGF-1R stimulates downstream proliferating 
pathways such as the PI3K/Akt (Laurino et al. 2005) and Ras signaling (Desbois-Mouthon et al. 
2001) resulting in increased human colon cancer cell proliferation. RSV could effectively 
suppress IGF-1R levels and downstream PI3K/Akt/beta-catenin signaling. This study, for the 
first time, demonstrated that RSV-GSE combination suppressed IGF-1 stimulated HCT-116 
colon cancer cell proliferation and induced apoptosis suggesting its potential role as a 
chemopreventive agent against colon cancer even in obese subjects.   
In summary, the current study revealed that RSV and GSE act in concert with each other 
in potentiating their anti-cancer properties in human colon cancer cell line HCT-116 via p53 
dependent mechanisms, but not in normal CRL-1831 colon epithelial cells. Thus, these results 
established the molecular basis for the beneficial effect of RSV-GSE combination that is a 





formation of a variety of potent bioactive metabolites that possess chemoprotective effect in 
animal/human models at even lower concentration compared to the present in vitro combinations 
used in the study (Tessitore et al. 2000; Banerjee et al. 2002; Li et al. 2002; Vanamala et al. 
2010). However, current knowledge on the effect of RSV-GSE combination is based mainly on 
our in vitro study. In vivo studies are needed to confirm these results, especially in the colon 
using sporadic/spontaneous colon cancer mice models, so that this system can be manipulated for 
the prevention and treatment of colon cancer. 
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PURPLE-FLESHED POTATOES REVERSED HIGH-FAT DIET ELEVATED OXIDATIVE 
STRESS AND INNATE INFLAMMATION MARKERS IN A PIG MODEL. 
 
4.1 Summary 
Intake of anthocyanins and anthocyanin-rich fruits has shown to suppress risk of colon 
inflammation, colon cancer and other chronic diseases. Although consumption of white-fleshed 
potatoes declined, consumption of color-fleshed potatoes, rich in anthocyanins and other 
bioactive compounds, increased by 17 % in the US in 2009-10. This may be partly attributed to 
the putative health benefits of anthocyanins and other bioactive constituents. However, little 
information exists if purple-fleshed potatoes, rich in anti-oxidant and anti-inflammatory 
anthocyanins, even after processing, retain their health benefiting properties in vivo. We 
hypothesized that processed (chipped) purple-fleshed potatoes will retain bioactivity and 
suppress high-fat diet (HFD) elevated oxidative stress/inflammation biomarkers in a pig model. 
We conducted a study, where 40 pigs (12 weeks on HFD, n=8/group) consumed HFD or HFD 
containing 10 or 20 % w/w purple or white-fleshed potato chips for an additional 5 weeks. 
Analytical (UPLC-MS) data on purple and white-fleshed potato chips showed significant 
differences in metabolite profiles between the two cultivars. In the animal study, the purple-
fleshed potato diets had no effect on food intake and weight gain at the end of the study. In the 
distal colon, only the purple-fleshed potato consuming animals (P10) had elevated GSH:GSSG 
ratio (oxidative stress marker, P = 0.05) and lower expression of inflammatory markers (P10 and 





HFD controls; levels in the white-fleshed potato consuming animals were not significantly 
different from the HFD control animals. Similar results were obtained in the mesenteric fat, as 
only the purple-fleshed potato consuming animals (P10) had greater GSH:GSSG ratio and 
adiponectin expression (P = 0.1) and lower TNF-α expression (P10 and P20, P = 0.05) compared 
to the HFD control animals. Systemic markers of oxidative stress were suppressed in the purple-
fleshed group P10 compared to control. Results of this intervention study suggest that the 
consumption of purple-fleshed potato chips reversed HFD elevated oxidative and inflammatory 
biomarkers in the distal colon, mesenteric fat and the systemic circulation; lending support to the 
health benefits of purple-fleshed potato consumption. 
 
4.2 Introduction 
Consumption of a diet rich in fat and low in anti-oxidants is linked to chronic low-grade 
oxidative stress and inflammation that are conducive for development of disorders like colon 
cancer (Erdelyi, Levenkova et al. 2009). Animals provided with high-fat diet (HFD) have 
demonstrated elevated oxidative stress in various tissues and in systemic circulation (Wisse 
2004, Berg and Scherer 2005, Shoelson, Herrero et al. 2007, Erdelyi, Levenkova et al. 2009). 
Indeed, reactive oxygen species (ROS) production was upregulated in the adipose tissue (and the 
liver) of C57BL/6J mice consuming a HFD (Matsuzawa-Nagata, Takamura et al. 2008). In a 
Western diet consuming mouse model of sporadic colon cancer, oxidative stress and altered 
immune responses occurred long before tumors in the colon (Erdelyi, Levenkova et al. 2009).  
Oxidative stress and inflammatory processes are very well connected as elevated 
oxidative stress can activate inflammatory pathways via the NF-B signaling (Solinas and Karin 





microenvironment where ROS are released from inflammatory cells. ROS can cause DNA 
damage and elevate risk for colorectal cancer (Pot, Geelen et al. 2010). Studies have shown that 
HFD consuming rodent models have dysregulated gut microbiota with greater numbers of 
harmful bacteria (Kim, Gu et al. 2012) and elevated gut inflammation (Ding, Chi et al. 2010, 
Kim, Gu et al. 2012). HFD induced altered gut bacteria and TLR activation are key elements for 
induction of the innate inflammatory response via triggering signaling cascades including the 
transcription factor NF-B (Takeda and Akira 2004). Indeed, mice consuming HFD had elevated 
colonic inflammation indexed by the elevated expression of pro-inflammatory cytokines, the 
induction of TLR-4, iNOS, COX-2, and the activation of NF-B compared to the control mice 
(Kim, Gu et al. 2012).  
Current body of evidence supports the role of the gut in visceral fat dysfunction (Drouet, 
Dubuquoy et al. 2012). Colonic inflammation and altered gut bacterial diversity results in an 
increase in paracellular permeability of the colon and subsequent translocation of harmful 
bacteria and bacterial products (LPS, flagellin etc.) into the adjacent mesenteric fat (Gambero, 
Marostica et al. 2007, Lam, Mitchell et al. 2011). Indeed, in animal and human models of Crohns 
disease, an inflammatory condition of the colon, the mesenteric fat gets inflamed. Inflamed 
mesenteric fat exhibited elevated pro-inflammatory gene expression and cytokine production, 
adipocyte hypertrophy, leading to macrophage infiltration and activation over time (Gambero, 
Marostica et al. 2007, Maury and Brichard 2010, Lam, Mitchell et al. 2011). The adipose-derived 
cytokines and increased fatty acid flux from the expanded fat mass have been associated to 
systemic dysfunction and feed forward to further exacerbate the intestinal and adipose 





Elevated adipose inflammation can contribute to elevated circulating inflammatory 
markers like TNF-α and IL-6 (Arkan, Hevener et al. 2005, Bastard, Maachi et al. 2006, 
Shoelson, Herrero et al. 2007). TNF-α is over expressed in adipose tissue and plays an important 
role in mediating the insulin resistance (Berg and Scherer 2005). In addition, HFD consuming 
animal models had elevated ROS production in the adipose tissue (Matsuzawa-Nagata, 
Takamura et al. 2008), which can damage lipids. In particular, unsaturated fatty acids are 
susceptible to ROS damage leading to formation of reactive intermediates such as 8-isoprostane 
and malondialdehyde, biomarkers in urine/serum for measuring systemic oxidative stress (Apel 
and Hirt 2004).  
Foods abundant in bioactive polyphenols have demonstrated anti-oxidant and anti-
inflammatory properties in multiple models both in vitro and in vivo (Rossi, Serraino et al. 2003, 
Pan, Lai et al. 2009, Chuang and McIntosh 2011). Several studies have demonstrated an 
inhibitory effect of polyphenols on the NF-B activation pathways in intestinal models of 
inflammation (Hogan, Canning et al. 2010, Umesalma and Sudhandiran 2010, Chuang and 
McIntosh 2011, Piberger, Oehme et al. 2011). Most studies, however, have been conducted with 
individual standard polyphenols or plant extracts. However epidemiological studies supporting 
an anti-inflammatory role for polyphenols are on whole foods including fruits and vegetables, 
that contain complex mixtures of polyphenols (Romier-Crouzet, Van De Walle et al. 2009). 
The potato (Solanum tuberosum L.) is the world’s 4th largest food crop with over 300 
million tons of global production per year. The potato is the most consumed vegetable crop in 
the US with per capita consumption of approximately 52 kg/person/year (NPC 2010). Due to its 
high consumption, it is considered as the third largest source of phenolic compounds in the 





phenolic acids and anthocyanins. We and others have shown that phenolic acids are present at 
amounts 5-12 times higher in purple-fleshed potatoes compared to white-fleshed potatoes 
(Rodriguez-Saona, Giusti et al. 1998, Brown 2005, Madiwale, Reddivari et al. 2011, 
Radhakrishnan, Reddivari et al. 2011). Recently, we reported that purple-fleshed potatoes were 
more efficient than white- or yellow-fleshed potatoes in suppressing proliferation and elevating 
apoptosis in early (HCT-116) and advanced (HT-29) stage human colon cancer cell lines 
(Madiwale, Reddivari et al. 2011, Madiwale, Reddivari et al. 2012). However, unlike other 
anthocyanin-rich sources such as blueberries, potatoes are almost always processed before 
consumption (Brown 2005, Walton, Lentle et al. 2006, NPC 2007). Thus, it is important to test if 
processed purple-fleshed potatoes exert anti-oxidant and anti-inflammatory properties in vivo, as 
this aspect has received little consideration.  
To determine extent to which purple-fleshed potatoes, even after chipping, suppress HFD 
elevated oxidative stress and inflammatory markers in vivo compared to white-fleshed potato, 40 
pigs (on HFD for 12 weeks; > 130 kg) were provided with HFD and HFD containing 10 or 20 % 
purple or white-fleshed potato chips for additional 5 weeks (n = 8). We hypothesized that dietary 
supplementation with 10-20 % purple-fleshed potato chips will reverse the elevated oxidative 
stress/inflammation biomarkers in the distal colon, mesenteric fat and systemic circulation 
compared to the HFD consuming controls. We used the pig as an animal model due to similar 
nutrient metabolism, and gut anatomy, and physiology to humans (Cooper, Berry et al. 1997, 
Pond and Lei 2000). Evaluation of the anti-oxidant and anti-inflammatory effects of purple-
fleshed potato bioactive compounds in HFD consuming pigs might provide evidence for the 






4.3 Materials and Methods 
All protocols for the use of animals in this study were approved by both the Colorado 
State University Institutional Animal Care and Use Committee (CSU-IACUC) and the North 




Forty male pigs, (3 weeks post weaning, breed: SPG), were obtained from Murphy-
Brown LLC (Warsaw, NC) and were individually housed in solid concrete floor indoor pens at 
the North Carolina State University Swine Educational Unit (Raleigh, NC). Pigs were provided 
at 6 weeks age with HFD (C, Table 4.1) for 12 weeks until they are ~130 kg. The animals were 
grouped, so that mean initial body weight was similar among the treatment groups (n = 8 
animals/treatment). Initial average body weight was 133.3 ± 1.2 kg. All the animals completed 
the study and no adverse side effects were reported. 
 
4.3.2 Experimental Diets 
After 12 weeks of consuming HFD, pigs were assigned to one of the 5 iso-caloric high-
fat dietary groups; Control (no potato), and purple- and white-fleshed potato chips at 10 and 20 
% of the diet (w/w). Purple-fleshed potatoes (Purple Majesty) and white-fleshed (Atlantic) 
potatoes were grown at Black Gold Farms (Pearsall, TX), and were chipped and fried in the 
industrial collaborators facility at H. E. B. (San Antonio, TX). We have previously characterized 
the anthocyanin, phenolic acid and anti-oxidant properties of Purple Majesty and Atlantic 





analysis (IEH-Warren Laboratory, Greeley, CO) before incorporation into diet to ensure that 
macronutrient composition was similar across the groups. Composition of all the diets is 
presented in Table 4.1. Pigs consumed the experimental diets for 5 weeks (35 days); the feed and 
drinking water were provided ad libitum. Body weight, weight gain and feed intake were 







Table 4.1 Composition of diets used in the study. 
 Control Purple Chips White Chips 
Ingredients (%) C P10 P20 W10 W20 
White Corn 72.80 65.80 58.80 65.80 58.80 
Purple-fleshed Potato Chips  0.00 10.00 20.00 0.00 0.00 
White-fleshed Potato Chips  0.00 0.00 0.00 10.00 20.00 
Soybean meal w/o Hulls 15.00 15.00 15.00 15.00 15.00 
Trace Mineral Premix 0.15 0.15 0.15 0.15 0.15 
Salt 0.32 0.32 0.32 0.32 0.32 
NCSU Vit AgPro 0.03 0.03 0.03 0.03 0.03 
Poultry Fat 5.00 3.50 2.00 3.50 2.00 
Dry Fat 5.00 3.50 2.00 3.50 2.00 
Di-Calcium Phosphate 1.00 1.00 1.00 1.00 1.00 
Limestone 0.70 0.70 0.70 0.70 0.70 
Total 100.00 100.00 100.00 100.00 100.00 
Calculated Composition (% unless mentioned) 
Dry Matter 90.5 91.0 91.6 91.0 91.6 
Metabolizable Energy, Cal/kg 3810 3800 3800 3800 3800 
Crude Protein 13.2 13.0 12.8 13.0 12.8 





Methionine 0.47 0.47 0.46 0.47 0.46 
Tryptophan 0.14 0.14 0.14 0.14 0.14 
Threonine 0.49 0.48 0.48 0.48 0.48 
Crude Fat 12.91 12.93 12.95 12.93 12.95 
Calcium 0.60 0.60 0.60 0.60 0.60 
Available Phosphorus 0.23 0.23 0.23 0.23 0.23 
Phosphorous 0.49 0.48 0.48 0.48 0.48 
C: High-fat diet control, P10 and P20 - purple-fleshed potato chips at 10 and 20 % of diet w/w and W10 and W20 - 







4.3.3 Blood, Urine and Tissue Collection 
The animals were euthanized at the end of study using a captive bolt method. At 
termination, jugular vein blood was collected without anticoagulant and serum was stored at −80 
°C for biochemical analysis. Urine was collected at the end of the study in falcon tubes. Once 
collected, urine samples were stored at −20 °C for a day and transferred to −80 °C for long term 
storage until analysis. The distal colon was resected and cleaned with RNAse-free phosphate-
buffered saline. The mucosa was scraped using a glass slide into an RNAse free tube, 
immediately snap frozen in liquid nitrogen, and later transferred to −80 °C for long term storage. 
Mesenteric fat was collected, cleaned with RNAse free phosphate buffered saline, snap frozen in 
liquid nitrogen and stored at −80 °C prior to analysis. 
 
4.3.4 Tissue Oxidative Stress  
Glutathione levels (GSH: reduced and GSSG: oxidized) were measured in the distal 
colon and the mesenteric fat using UPLC/PDA (Waters ACQUITY UPLC H-class system) 
according to the HPLC method of Yilmaz et al (Yilmaz, Keser et al. 2009) with minor 
modifications. In particular, the protocol (solvent flow rate, total run time) was modified for the 
UPLC system using the Waters Empower 3 software. 
 
4.3.5 Real Time Polymerase Chain Reaction 
Real-time PCR analysis was used to measure the gene expression of pro-inflammatory 
and anti-inflammatory markers in the distal colon mucosa and the mesenteric fat. Total RNA was 
extracted using the Phenol-Free Total RNA Purification Kit (Amresco, Solon, OH) and cDNA 





Gaithersburg, MD), according to the manufacturer’s instructions. Real-time PCR was performed 
using qPCR SYBR Green Supermix (Quanta Biosciences) on an Illumina Eco instrument (San 
Diego, CA). Messenger RNA expression of genes was calculated using the Eco and Eco Study 












Gene Forward Primer Sequence  Reverse Primer Sequence  Product Length (bp) 
Actin GGCCGGGACCTGACCGACTA GGAGGAGGAGGAGGCGGCC 162 
Adiponectin GCGAATGGGCATGTTAGGGA AAATCCGGGGCAGAAAAGGA 107 
COX-2 CATTGATGCCATGGAGCTGTA CTCCCCAAAGATGGCATCTG 70 
IL-10 TGATGGGGAGGATATCAAGG TGATGGGGAGGATATCAAGG 150 
NF-B CCCATGTAGACAGCACCACCTATGAT ACAGAGGCTCAAAGTTCTCCACCA 132 
TGF-β CGAGCCCTGGATACCAACTA AGGCTCCAGATGTAGGGACA 164 
TLR-2 CAGTCCGGAGGTTGCATATT ATGCTGTGAAAGGGAACAGG 137 
TLR-4 ATGGCCTTTCTCTCCTGCCTGA AGGTCCAGTATCTTGACTGATGTGGG 139 





4.3.6 Systemic Oxidative Stress Markers 
Serum samples were analyzed for oxidative stress markers, 8-isoprostane – free and 
bound, and malondialdehyde using an ELISA and Thiobarbituric Acid Reactive Substances 
(TBARS) assay kit, respectively, following the manufacturer’s protocol (Cayman, Ann Harbor, 
MI). The oxygen radical absorbance capacity (ORAC) value of serum was calculated based on 
the previously published method (Huang, Ou et al. 2002). Urine samples were analyzed for 
oxidative stress markers 8-isoprostane and DNA adduct 8-hydroxy-2′-deoxyguanosine (8-
OHDG) following manufacturer’s protocol (Cayman). Urinary concentrations were normalized 
to creatinine levels measured using a colorimetric kit (Cayman).  
 
4.3.7 Serum Inflammatory Markers 
Inflammatory markers, TNF-α (Swine ELISA, Life Technologies, Grand Island, NY), 
leukotriene B4 (LTB4, Cayman), lipopolysaccharide (LPS, Limulus Amebocyte Lysate Kit, 
Lonza, Basel Switzerland) and acute phase C-reactive protein (CRP ELISA; Life Diagnostics, 
West Chester, PA) were analyzed in the serum based on the manufacturer’s protocols.  
 
4.3.8 Statistical Analysis 
Completely randomized block design was used in this study. Individual pigs were the 
experimental unit. Data were analyzed using the MIXED procedure in SAS (SAS Institute, Cary, 









4.4.1 UPLC-MS Profile of Phenolic Compounds in Potato Chips 
Typical total ion chromatograms (TIC, Figure 4.1A) illustrated differences between the 
purple (top panel) and the white-fleshed potato chip extracts. From the LC-MS analysis, a total 
of 2352 ions characterized by a mass to charge ratio and a retention time were represented as 
points on the volcano plot (Figure 4.1B). Each ion on this graph is represented according to its P-
value (y-axis) and fold change (x-axis). Features/ions located on the right indicate those which 
are abundant in purple-fleshed potato; and those on the left indicate that are abundant in the 
white-fleshed potato. We gated the graph (in red lines) using a P value ≤ 0.01 to be significantly 
altered and fold change of 4 between two varieties. Thus, 466 features were significantly higher 
in purple-fleshed potato compared to white-fleshed potato, whereas only 62 features were higher 
in the white-fleshed potato (P value ≤ 0.01, fold change > 4). 825 features were not significantly 
different between the two potato varieties whereas 999 features were significantly different (P ≤ 
0.01) but fold change difference between varieties was ≤ 4. Thus, we observed that number of 
significant features with higher abundance was more in the purple-fleshed potato compared to 
the white-fleshed potato. Peak annotations using METLIN metabolite database were presented in 
Table 4.3. Phenolic acids (chlorogenic acid and p-coumaric acid) were detected in both white 
and purple-fleshed varieties; however, the relative abundance was higher in the purple-fleshed 
potato. Glycosylated anthocyanins were only detected in the purple-fleshed potato and are 






Figure 4.1A Typical total ion chromatograms from LC/MS analysis of purple- (top) and white- 
(bottom) fleshed potato phenolic extracts. 
 
Figure 4.1B Volcano plot of the 2352 features (mass by charge ratio/retention time) obtained 





white-(Atlantic) fleshed potato varieties. Each point (ion) on this graph is represented according 
to its –Log10 (P value) on the y-axis and Log2 (fold change) on the x-axis. The plot was gated 
(red lines) using a P value ≤ 0.01 and a fold change ≥ 4 to display differences between the two 







Table 4.3 Phenolic and anthocyanin composition of potato chips by UPLC/MS 
 
Compound Identity Molecular Ion M+ (m/z) Retention Time (minutes) White-fleshed Potato Chips Purple-fleshed Potato Chips 
Phenolic Acids 
P-coumaric acid 165.1 5.55 527.5 ± 41.9 544.5 ± 23.2 
Chlorogenic acid 355.1 6.08 6543.5 ± 35.9 15176.6 ± 73.9 
Anthocyanins 
Pet-3-rut-5-glc 787.3 5.79 0.0 1578.6 ± 105.7 
Mal-3-rut-5-glc 801.3 6.19 0.0 237.5 ± 14.8 
Cya-3-O(6-O-malonyl-β-D-glc) 535.1 6.37 0.0 691.1 ± 3.2 
Peo-3-(p-coum)-isophoro-5-glc 933.3 7.26 0.0 2729.2 ± 275.7 
Peo-3-rut-5-glc 771.3 7.80 0.0 2871.1 ± 29.9 
Pet-3-(p-coum)-rut-5-glc 933.3 7.92 0.0 28748.5 ± 235.7 
Peo-3-caffeyl-rut-5-glc 933.3 8.03 0.0 27215.4 ± 2295.1 
Pel-3-(p-coum)-rut-5-glc 887.3 8.11 0.0 80.8 ± 5.4 
Pel-3-(4'''-ferul-rut)-5-glc 917.3 8.15 0.0 1569.3 ± 142.7 
Peo-3-(p-coum)-rut-5-glc 917.3 8.21 0.0 1810.2 ± 135.2 
Mal-3-(p-coum)-rut-5-glc 947.3 8.31 0.0 2707.4 ± 204.4 





4.4.2 Physical Parameters  
Initial body weight of pigs did not differ among treatments. There were no significant 
differences in overall feed intake and overall weight gain among four treatment groups at week 5 
(C, P10, P20 and W10), however, W20 group had lower overall feed intake and weight gain 
compared to control (P ≤ 0.05, Table 4.4). However, by week 5, there were no significant 
differences in body weight, weight gain or feed intake among the 5 treatment groups. It should 
be noted that, overall feed conversion ratio, weight gain/feed consumed, did not differ among the 
five groups of animals at the end of the study (0.3 ± 0.1 for all groups, Appendix I). No 
significant differences were observed among treatment groups in back-fat thickness (Appendix 





Table 4.4 Growth performances (body weight, weight gain and feed intake) of pigs consuming experimental diets during the 5 week 
feeding period. 
Dietary Group Week 0 Week 1 Week 2 Week 3 Week 4 Week 5  
 Body Weight (kg)  
C 134.5 ± 2.9a 140.1 ± 3.3a 145.8 ± 3.7a 151.0 ± 4.1a 153.6 ± 3.9a 158.6 ± 4.0a  
P10 133.6 ± 2.1a 139.7 ± 2.2a 143.6 ± 2.4a 150.0 ± 2.4a 154.0 ± 2.3a 157.7 ± 2.1a  
P20 133.2 ± 2.6a 133.9 ± 2.8b 139.8 ± 3.1ab 144.8 ± 2.4a 151.6 ± 3.2a 155.5 ± 3.5a  
W10 132.3 ± 3.0a 137.6 ± 3.2ab 141.2 ± 3.6ab 146.4 ± 3.1a 150.1 ± 3.1a 153.8 ± 3.2a  
W20 132.8 ± 2.8a 132.4 ± 3.5b 134.6 ± 4.3b 143.6 ± 4.2a 147.1 ± 3.7a 150.0 ± 3.4a  
 Average Daily Gain (kg/d) Overall Weight 
 Gain (kg/d) 
C  0.8 ± 0.1a 0.8 ± 0.1a 0.7 ± 0.1a 0.4 ± 0.1a 0.7 ± 0.1a 0.7 ± 0.0a 
P10  0.9 ± 0.1a 0.6 ± 0.1ab 0.9 ± 0.1a 0.6 ± 0.1ab 0.5 ± 0.1a 0.7 ± 0.0a 
P20  0.1 ± 0.3b 0.8 ± 0.1a 0.7 ± 0.2a 1.0 ± 0.2b 0.6 ± 0.1a 0.6 ± 0.0ab 
W10  0.8 ± 0.1a 0.5 ± 0.1ab 0.7 ± 0.1a 0.5 ± 0.1a 0.5 ± 0.1a 0.6 ± 0.0ab 










 Average Daily Feed Intake (kg/d) Overall Feed  
Consumed (kg/d) 
C   2.8 ± 0.1a 2.4 ± 0.1a 2.6 ± 0.1a 2.1 ± 0.1a 1.9 ± 0.1a 2.4 ± 0.1a 
P10  2.5 ± 0.2a 2.2 ± 0.1ab 2.6 ± 0.1a 2.2 ± 0.1a 2.0 ± 0.1a 2.3 ± 0.1a 
P20  1.3 ± 0.3b 2.1 ± 0.2ab 2.6 ± 0.1a 2.5 ± 0.2a 2.1 ± 0.1a 2.1 ± 0.1ab 
W10  2.1 ± 0.3a 2.0 ± 0.1ab 2.4 ± 0.1a 2.0 ± 0.1a 1.7 ± 0.1a 2.1 ± 0.1ab 
W20  1.1 ± 0.3b 1.8 ± 0.3b 2.3 ± 0.2a 2.1 ± 0.1a 1.9 ± 0.1a 1.8 ± 0.1b 
Data are presented as means ± S.E. Means in columns (within a week between treatment groups) that differ by a common letter (a, b) differ 
(P ≤ 0.05). C: High-fat diet control, P10 and P20 - purple-fleshed potato chips at 10 and 20 % of diet w/w and W10 and W20 - white-





4.4.3 Colonic GSH:GSSG Ratio  
Glutathione is an intracellular anti-oxidant in cells. Glutathione exists in two forms 
reduced (GSH) and oxidized (GSSG). When cells are exposed to increased levels of oxidative 
stress, GSSG accumulates and the ratio of GSH to GSSG decreases. Therefore, the determination 
of the GSH:GSSG ratio is a useful indicator of oxidative stress in animal tissues (Owen and 
Butterfield 2010). We measured GSH:GSSG ratio in the distal colon of the animals. The animals 
consuming HFD for the entire duration of the study (C) had lower GSH:GSSG ratio compared to 
animals in the potato groups. GSH:GSSG ratio was significantly higher only in the animals 
consuming purple-fleshed potato chips at 10 % (P10) compared to the HFD control (P = 0.05, 
Figure 4.2). This suggests that the color of the potato and the supplementation levels are 
important considerations to suppress HFD induced oxidative stress indexed by glutathione redox 
ratio in the distal colon. 
 
Figure 4.2 Glutathione (GSH-reduced and GSSG-oxidized) were measured in the distal colon 
using UPLC/PDA. Results were expressed as mean ± S.E. for 7-8 animals in each treatment 





letters P and W indicate the chipped purple and white-fleshed potato diets and the numbers 10 
and 20 indicate 10 and 20 % potato supplementation in the diet (w/w).  
 
4.4.4 Colonic Inflammatory Markers 
We measured expression of a panel of innate inflammatory markers in distal colon 
mucosa using qPCR. Relative expression of the pro-inflammatory markers including NF-B, 
TNF-α, TLRs 2 and 4 were suppressed, irrespective of dosage, only in the purple-fleshed potato 
diet groups compared to the animals on HFD control (NF-B, P = 0.05; TNF-α, P = 0.05; TLR-
2, P = 0.02; and TLR-4, P = 0.02). The relative expression of TLR-2 and TLR-4 in the white-
fleshed potato diet group were not statistically significant compared to HFD control or the 
purple-fleshed potato diet group (Figures 4.3 A-C). We measured relative expression of anti-
inflammatory cytokines IL-10 and TGF-β in the distal colon mucosa of these animals. There 
were no significant differences among groups (Figure 4.3 D).  
 
Figure 4.3A Relative expression of TLR-4 and NF-кB as measured using real time PCR in the 
distal colon mucosa. Results were expressed as mean ± S.E. for 7-8 animals in each treatment 





letters P and W indicate the chipped purple and white-fleshed potato diets and the numbers 10 
and 20 indicate 10 and 20 % potato supplementation in the diet (w/w).  
 
Figure 4.3B Relative expression of TNF-α and COX-2 as measured using real time PCR in the 
distal colon mucosa. Results were expressed as mean ± S.E. for 7-8 animals in each treatment 
group. Means that differ by a common letter (a, b) differ (P ≤ 0.05). C, high-fat diet control, 
letters P and W indicate the chipped purple and white-fleshed potato diets and the numbers 10 
and 20 indicate 10 and 20 % potato supplementation in the diet (w/w).  
 
Figure 4.3C Relative expression of TLR-2 as measured using real time PCR in the distal colon 
mucosa. Results were expressed as mean ± S.E. for 7-8 animals in each treatment group. Means 





indicate the chipped purple and white-fleshed potato diets and the numbers 10 and 20 indicate 10 
and 20 % potato supplementation in the diet (w/w).  
 
Figure 4.3D Relative expression of IL-10 and TGF-β as measured using real time PCR in the 
distal colon mucosa. Results were expressed as mean ± S.E. for 7-8 animals in each treatment 
group. Means that differ by a common letter (a, b) differ (P ≤ 0.05). C, high-fat diet control, 
letters P and W indicate the chipped purple and white-fleshed potato diets and the numbers 10 
and 20 indicate 10 and 20 % potato supplementation in the diet (w/w).  
 
4.4.5 Mesenteric Fat GSH:GSSG Ratio 
As a marker for oxidative stress, we measured GSH:GSSG ratio in the mesenteric fat of 
the animals. Only the purple-fleshed potato consuming animals, P10 group, tended to have 
higher mesenteric fat GSH:GSSG ratio compared to the HFD controls (P = 0.1). GSH:GSSG 
ratio in animals in the white-fleshed potato groups were not significantly different compared to 






Figure 4.4 Glutathione (GSH-reduced and GSSG-oxidized) were measured in the mesenteric fat 
using UPLC/PDA. Results were expressed as mean ± S.E. for 7-8 animals in each treatment 
group. Means that differ by a common letter (a, b) differ (P ≤ 0.05). C, high-fat diet control, 
letters P and W indicate the chipped purple and white-fleshed potato diets and the numbers 10 
and 20 indicate 10 and 20 % potato supplementation in the diet (w/w).  
 
4.4.6 Mesenteric Fat Inflammatory Markers 
We measured relative expression of the innate inflammatory markers in the mesenteric 
fat. Only the animals consuming purple-fleshed potato (P10 and P20) had suppressed TNF-α (P 
= 0.05) and numerically lower NF-B and TLR-4 (P ≤ 0.15) expression in the mesenteric fat 
compared to the HFD control animals (Figure 4.5 A, 4.5 B). Mesenteric fat expression of TNF-α, 
NF-B and TLR-4 in the animals consuming white-fleshed potato diet W10 was similar to the 
purple-fleshed potato groups (Figure 4.5 A, 4.5 B). 
 Expression of adiponectin, an anti-inflammatory adipokine and an insulin sensitizer, was 





control and the white-fleshed potato (Figure 4.5 A, P ≤ 0.05). In addition, expression of anti-
inflammatory cytokines IL-10 and TGF-β were higher in the animals consuming purple-fleshed 
potato P10 compared to the animals on the white-fleshed potato diets, however, were not 
significantly different from HFD control group (Figure 4.5 C, P ≤ 0.05). 
 
Figure 4.5A Relative expression of TNF-α and adiponectin as measured using real time PCR in 
the mesenteric fat. Results were expressed as mean ± S.E. for 7-8 animals in each treatment 
group. Means that differ by a common letter (a, b) differ (P ≤ 0.05). C, high-fat diet control, 
letters P and W indicate the chipped purple and white-fleshed potato diets and the numbers 10 
and 20 indicate 10 and 20 % potato supplementation in the diet (w/w).  
 
Figure 4.5B Relative expression of TLR-4 and NF-B as measured using real time PCR in the 





Means that differ by a common letter (a, b) differ (P ≤ 0.05). C, high-fat diet control, letters P 
and W indicate the chipped purple and white-fleshed potato diets and the numbers 10 and 20 
indicate 10 and 20 % potato supplementation in the diet (w/w).  
 
Figure 4.5C Relative expression of IL-10 and TGF-β as measured using real time PCR in the 
mesenteric fat. Results were expressed as mean ± S.E. for 7-8 animals in each treatment group. 
Means that differ by a common letter (a, b, c) differ (P ≤ 0.05). C, high-fat diet control, letters P 
and W indicate the chipped purple and white-fleshed potato diets and the numbers 10 and 20 
indicate 10 and 20 % potato supplementation in the diet (w/w).  
 
4.4.7 Systemic Oxidative Stress Markers 
Serum 8-isoprostane (8IP) concentrations (pg/ml) were lower in both purple-fleshed 
potato diet (P10; P ≤ 0.03, P20; P ≤ 0.04) consuming groups compared to HFD control (Figure 
4.6). Serum concentration (µmol/L) of MDA, a lipid peroxidation marker, tended to be 
suppressed by the P10 diet compared to HFD control (Figure 4.6, P ≤ 0.07 for P10). There was a 
significant correlation between MDA and 8IP (P ≤ 0.03; r = 0.54). However, there were no 





deoxyguanosine among the treatment groups (Appendix II). Potato consumption did not 
significantly elevate serum total anti-oxidant status (Appendix II).  
 
Figure 4.6 8-isoprostane was measured using ELISA following manufacturers protocol 
(Cayman). Malondialdehyde was measured using a colorimetric TBARS assay (Cayman). TNF-
α was measured in porcine serum using ELISA following manufacturers protocol (Life 
Technologies). Results were expressed as mean ± S.E. for 7-8 animals in each treatment group. 
Means that differ by a common letter (a, b) differ (P ≤ 0.05). C, high-fat diet control, letters P 
and W indicate the chipped purple and white-fleshed potato diets and the numbers 10 and 20 






4.4.8 Serum Inflammatory Markers 
Serum TNF-α concentration was lower in purple-fleshed potato diet (P ≤ 0.05) 
consuming animals compared to HFD control. Even the white-fleshed potato consuming 
animals, W10, had lower TNF-α concentration (P ≤ 0.05) compared to HFD control animals 
(Figure 4.6). However, there were no significant differences among treatments in serum 
concentrations of other inflammatory markers including C-reactive protein, lipopolysaccharide, 
and the eicosanoid LTB4 (Appendix II) among the treatment groups.  
 
4.5 Discussion  
Our results demonstrate that processed purple-fleshed potato supplementation in the diet 
of the HFD consuming animals reversed the elevated oxidative stress and inflammation 
biomarkers in the distal colon, mesenteric fat and systemic circulation, compared to HFD 
controls. 
We measured the differences in the phenolic profile between white and purple-fleshed 
potato chips using UPLC/MS. In the volcano plot (Figure 4.1B), over 400 features were higher in 
purple-fleshed potato compared to white-fleshed potato, whereas only 62 features were higher in 
the white-fleshed potato (P value ≤ 0.01, fold change > 4). This shows that the white-fleshed 
potatoes have certain phenolic compounds in higher abundance over the purple-fleshed cultivars 
although the number is significantly less. Moreover, from table 4.1, it is evident that both purple- 
and white-fleshed potatoes retained phenolic acids post processing into chips. Anthocyanins, 







4.5.1 Purple-fleshed Potato Reversed Colonic and Mesenteric Fat Oxidative Stress 
(GSH:GSSG Ratio) in HFD Consuming Animals. 
The GSH and GSH disulfide (GSSG) systems play a critical role in determining 
intracellular redox balance and antioxidant function. GSH has a central role as a tissue 
antioxidant and its oxidative product GSSG, is reduced back to GSH by GSSG reductase. GSH 
in the gut lumen is required for normal intestinal function because its antioxidant functions 
protect the lumen from damage by ROS (Benton, Liang et al. 2012). Depletion of GSH can lead 
to degeneration of colonic epithelial cells in mice and is also associated with upregulated levels 
of pro-inflammatory cytokines (Haddad 2011). Indeed, studies in animal models showed that 
intestinal ischemia, radiation injury, or infection is associated with a decrease in GSH in tissues 
and associated organ dysfunction (Holmes, Yong et al. 1998, Benton, Liang et al. 2012). 
Considering the apparent role of oxidative stress in inflammatory conditions of the colon, and the 
importance of GSH to the integrity of the colon (Holmes, Yong et al. 1998), we measured both 
GSH and GSSG in the distal colon using a highly sensitive UPLC/PDA method (Yilmaz, Keser 
et al. 2009). Our results demonstrate that only the consumption of purple-fleshed potato (P10) 
suppressed distal colonic oxidative stress as measured using GSH:GSSG ratio compared to HFD 
control (Figure 4.2).  
The adipose tissue is subjected to increased oxidative stress (Berg and Scherer 2005) in 
HFD consuming animal models (Charradi, Elkahoui et al. 2013). Elevated ROS seen in 
hypertrophied adipose tissue is accompanied by a decrease in mRNA expression levels and 
activities of antioxidant enzymes such as glutathione peroxidase (GPX), Cu/Zn superoxide 
dismutase (Cu/Zn SOD), and catalase, which are essential for homeostasis of the redox state and 





factor for the enzymatic function of GPXs on the reduction reaction and also acts as an 
antioxidant itself to scavenge ROS. The regulatory systems of intracellular GSH content and 
GSH/GSSG ratio are not well known in the adipose tissue, however as GSH itself is an 
antioxidant, accumulation of GSH will protect against ROS (Kobayashi, Matsuda et al. 2009). 
Our results suggest that in the mesenteric fat, the animals consuming purple-fleshed potato group 
P10 tended to have elevated GSH:GSSG ratio compared to the HFD controls (P = 0.1, Figure 
4.4). Thus, unlike the distal colon, in the mesenteric fat, purple-fleshed potato consumption 
provides only a modest anti-oxidant benefit as measured using GSH:GSSG ratio in HFD 
consuming pigs. 
 
4.5.2 Purple-fleshed Potato Reversed Colonic and Mesenteric Fat Inflammatory Markers 
in HFD Consuming Animals. 
HFD has shown to cause changes in the gut bacterial population – leading to elevated 
lipopolysaccharide (LPS) induced toll like receptor-4 (TLR4) activation in the colon (Li, Lelliott 
et al. 2008). Saturated fatty acids, typically present in Western diets, can activate TLRs directly 
and leading to innate inflammatory response not only in the colon, but also in the adipose tissue 
(Chait and Kim 2010, Maury and Brichard 2010). TLR activation is a key element for induction 
of the innate inflammatory response via triggering downstream signaling cascades including the 
transcription factor NF-B (Takeda and Akira 2004). Indeed, studies have shown elevated 
expression of both TLR-2 and TLR-4 in the colonic mucosa of children with inflammatory 
bowel disease (Szebeni, Veres et al. 2008); mice lacking TLR-4 were protected from HFD 
induced colonic inflammation and obesity (Kim, Gu et al. 2012). Thus, we measured expression 





In our study, only the purple-fleshed potato consuming animals had lower relative 
expression of TLR-2 and TLR-4 compared to the HFD control. There were no significant 
differences among the white-fleshed potato groups and the HFD controls (Figure 4.3 A, C). We 
measured relative expression of TLR-4 in the proximal colon and ileum mucosa of these animals 
in both studies. We did not observe any significant differences in the relative expression of TLR-
4 among the treatment groups (Appendix III). In addition, we did not see any significant 
alterations in the TLR-4 expression in the mesenteric fat (Figure 4.5 B). 
We measured relative expression of a broad panel of innate inflammatory mediators in 
the distal colon mucosa and mesenteric fat of these animals. Only the animals consuming purple-
fleshed potato supplemented diets had significantly lower distal colonic expression of NF-B 
and TNF-α compared to the HFD controls. Levels in the white-fleshed potato group did not 
differ significantly compared to the HFD control (Figure 4.3 A-C). This is in concert with earlier 
studies in colitis models, where anthocyanins have shown amelioration of experimental colitis 
(Piberger, Oehme et al. 2011, Wu, Xu et al. 2011). In particular, bilberry anthocyanins (Piberger, 
Oehme et al. 2011) in mice suppressed intestinal inflammation in acute and chronic DSS-colitis 
with significant suppression of TNF-α and IFN-γ.   
Since under physiological normal conditions a balance is maintained between pro- and 
anti-inflammatory indices, we measured relative expression of anti-inflammatory cytokines IL-
10 and TGF-β in the distal colon mucosa of these animals. There were no differences in the 
relative expression of anti-inflammatory cytokines; TGF-β and IL-10, among the treatment 
groups in the distal colon mucosa (Figure 4.3 D). Results suggest that the consumption of purple-
fleshed potatoes reversed elevated distal colonic inflammatory markers in HFD consuming 





the detrimental effects of HFD. We measured expression of NF-B and TNF-α in the proximal 
colon and ileum mucosa of these animals. We did not detect any significant difference among the 
animals consuming potato diets compared to the HFD control (Appendix III). 
Most adipokines with pro-inflammatory properties (e.g. TNF-α) are overproduced with 
increasing adiposity, while some anti-inflammatory adipokines like adiponectin are decreased 
(Berg and Scherer 2005, Maury and Brichard 2010). This dysregulation of adipokine production 
may promote risk for chronic diseases (Berg and Scherer 2005). Our results show that, the 
purple-fleshed potato consuming animals had lower mesenteric fat expression of TNF-α, a 
critical pro-inflammatory cytokine (Figure 4.5 A). In addition, expression of adiponectin was 
elevated in the P10 group compared to the HFD controls and the white-fleshed potato groups 
(Figure 4.5 A). However, there were no significant differences in NF-B expression in the 
mesenteric fat (Figure 4.5 B). Results demonstrate only a marginal beneficial effect of purple-
fleshed potato consumption on oxidative stress and inflammatory markers in the mesenteric fat. 
We measured expression of IL-10 and TGF-β in the mesenteric fat of these animals. The 
white-fleshed potato groups had the numerically lowest expression levels even when compared 
to the HFD controls. The animals in the P10 group had significantly elevated IL-10 and TGF-β 
expression compared to the white-fleshed potato consuming groups, however, were not different 
from the HFD controls (Figure 4.5 C).  
 
4.5.3 Purple-fleshed Potato Reversed Systemic Oxidative Stress Markers in HFD 
Consuming Animals. 
F2 isoprostanes are prostaglandin-F2-like compounds formed by oxidation of arachidonic 





8-isoprostane, one of the more prevalent F2 isoprostanes, in the plasma/serum and urine are 
regarded as one of the best indices of lipid peroxidation, and oxidative stress that are currently 
available (Montuschi, Barnes et al. 2004). Systemic 8-isoprostane concentrations are elevated in 
high-fat diet fed mice (Sandu, Song et al. 2005), and is an important oxidative stress biomarker 
in chronic diseases (Schwedhelm, Bartling et al. 2004, Kaviarasan, Muniandy et al. 2009).  
In our study, we measured both free and bound 8-isoprostane in the serum, and urine of 
the HFD consuming pigs. Both the purple-fleshed potato diets suppressed serum 8-isoprostane 
concentrations compared to HFD control. Serum concentrations of 8-isoprostane in white-
fleshed potato group were not significantly different from HFD control suggesting benefits of 
purple-fleshed potato consumption (Figure 4.6). However, no significant differences were seen 
in urinary 8-isoprostane concentrations among the treatments.  
To confirm suppression of oxidative stress, we measured MDA, which is an oxidative 
stress biomarker in systemic circulation and in tissue, used for over 30 years (Lykkesfeldt 2007). 
MDA is mainly produced in biological samples via peroxidation of polyunsaturated fatty acids 
with two or more methylene-interrupted double bonds or by enzymatic processes from various 
prostaglandins (Del Rio, Stewart et al. 2005). MDA is an important marker to measure systemic 
oxidative stress and is used in many studies employing dietary interventions in high-fat diet 
consuming animal models (Meng, Zhu et al. 2011, He, Wang et al. 2012). In our study, there was 
only a tendency for MDA to be suppressed in the animals consuming purple-fleshed potato diet 
(P10), Figure 4.6). There were no differences among HFD control and the white-fleshed potato 
diets consuming animals. Significant correlation observed between MDA and 8IP (P ≤ 0.03; r = 






4.5.4 Purple-fleshed Potato Suppressed Serum TNF-α in HFD Consuming Animals. 
 TNF-α is a critical pro-inflammatory cytokine and elevated levels of TNF-α in the 
systemic circulation are linked to variety of disorders. TNF-α is linked to heart disease, as it 
works with other pro-inflammatory cytokines, chemokines, and various immune cells towards 
the development of atherosclerotic lesions, the recruitment and activation of inflammatory cells, 
and the initiation of the inflammatory cascade inside the arterial wall. TNF-α also contributes to 
endothelial dysfunction in ischemia/reperfusion injury (Zhang, Xu et al. 2006, Gao, Xu et al. 
2007). TNF-α level in the blood were found to positively correlate with markers of insulin 
resistance in a community-based cohort study (Hivert, Sullivan et al. 2008, Ouchi, Parker et al. 
2011). Blocking TNF- α in mice reduced colorectal carcinogenesis associated with chronic 
colitis (Popivanova, Kitamura et al. 2008) – thus, TNF-α is an important target for anti-
inflammatory interventions against chronic diseases. 
The purple-fleshed potato groups (P10 and P20) and the white-fleshed potato group 
(W10) had lower concentrations of TNF-α compared to HFD control (Figure 4.6). Interestingly, 
similar expression profiles of TNF-α, and NF-κB and TLR-4 (non-significant, tends only) were 
seen in the mesenteric fat of these animals among the treatment groups (Figure 4.5 A-B). 
Although white-fleshed potatoes lack anthocyanins, they contain phenolic acids such as 
chlorogenic acid, caffeic acid, p-coumaric acid etc. that demonstrated anti-inflammatory 
properties in multiple studies (da Cunha, Duma et al. 2004, Chao, Mong et al. 2010, Chauhan, 
Satti et al. 2011). Indeed, we found 62 features that were higher and significantly different (fold 
change > 4 and P ≤ 0.01) in white-fleshed potato compared to purple-fleshed potato (Figure 
4.1B). Phenolics acids like caffeic acid, rich in white-fleshed potatoes, have shown TNF-α 





of Vitamin C, resistant starch and their contribution cannot be neglected. However, to elucidate 
the contribution of different bioactive compounds in the potato towards the in vivo anti-
inflammatory activity, further research is necessary. Our results, however, provide first in vivo 
evidence that purple-fleshed potatoes, even after processing, retain their anti-oxidant and anti-
inflammatory properties.  
 
4.5.5 Limitations of the Study 
Although, white-fleshed potatoes could not reverse the HFD elevated oxidative stress and 
inflammatory biomarkers in the distal colon, mesenteric fat and systemic circulation, there was a 
trend for beneficial effects of consuming white-fleshed potato. This study was short (5 weeks) 
and might explain the difference. However, purple-fleshed potato consumption demonstrated 
beneficial effects in the short time period suggesting the potent anti-inflammatory and anti-
oxidant efficacy of anthocyanins and higher phenolic acids present in the purple-fleshed potato.  
One limitation of the study is the lack of normal control animals to elucidate deleterious 
effect of consumption of a HFD. The study mentioned in ((Radhakrishnan, Reddivari et al. 
2012), Chapter V) employed a standard control, and we showed that standard control animals 
had lower systemic 8-isoprostane and TNF-α compared to pigs on a HFD. Another limitation of 
the study is the relatively high dose of potato chips (10-20 %) of diet; on an average the animals 
consume approximately 1.2-3 kg of chips per week. However, the potato is an important staple 
food for various populations around the world and it provides approximately 5 % to 15 % of 
dietary calories (Thompson, Thompson et al. 2009). It should be noted that over 80 % of potato 





It is interesting to note that in the present study, we found the 10 % purple-fleshed potato 
group was similar and in some cases more effective in modulating oxidative stress and 
inflammatory parameters than the 20 % dose. The phenomenon that lower doses can be equal or 
more effective than the higher doses has been observed with other phenolic compounds. For e.g., 
freeze dried mango supplementation in the HFD in mice at 1 % supplementation was more 
effective in improving glucose tolerance and lipid profile and reducing adiposity associated with 
a HF diet compared to 10 % supplementation (Lucas, Li et al. 2011). Moreover, a study by 
Marugundanan et al. (Muruganandan, Srinivasan et al. 2005) demonstrated that mangiferin at 10 
mg/kg is as effective as the 20 mg/kg dose for its anti-diabetic, anti-hyperlipidaemic and anti-
atherogenic activities in streptozotocin-diabetic rats.  
Moreover, potatoes are known to contain toxicants such as glycoalkaloids. As the 
potatoes were processed into chips, higher dosage of chips elevates consumption of processing 
induced toxin – acrylamide which is known to induce inflammation and is carcinogenic 
(Capuano and Fogliano 2011, Zhang, Wang et al. 2013). Thus, higher consumption of potato 
chips elevates the concentrations of these toxicants which might counter the health benefits of 
the bioactive compounds in the potato. Thus, we need to identify the optimal dose of foods and 
its bioactive compounds that exert a health benefit and not to work under the assumption that 











Studies in mice have shown that mucosal inflammation leads to systemic genotoxicity 
characterized by elevated systemic oxidative stress markers, DNA damage and inflammatory 
cytokines and contributes early on to genetic instability necessary for progression to 
inflammatory bowel disease-associated dysplasia and the development of cancer (Westbrook, 
Wei et al. 2009). Results of our study suggests that chipped purple-fleshed potatoes suppress 
oxidative stress and inflammatory markers in the distal colon, mesenteric fat, and systemic 
circulation and thus, may suppress risk for colon cancer and other chronic disorders linked with 
HFD. Due to high consumption of potatoes, purple-fleshed potatoes can be an effective delivery 
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PURPLE-FLESHED POTATOES PREVENTED HIGH-FAT DIET ELEVATED OXIDATIVE 
STRESS AND INNATE INFLAMMATION MARKERS IN A PIG MODEL. 
 
5.1 Summary 
Consumption of anthocyanins and anthocyanin-rich fruits has shown to suppress risk for 
colon inflammation, colon cancer, type 2 diabetes etc. Color-fleshed potato consumption 
increased by 17% in the US partly attributed to putative health benefits of bioactive constituents 
such as anthocyanins and phenolic acids. However, little information exists if purple-fleshed 
potatoes, rich in anti-oxidant and anti-inflammatory anthocyanins, even after processing, retain 
their health benefiting properties in vivo. We hypothesized that processed (raw vs. baked vs. 
chips) purple-fleshed potatoes will suppress high-fat diet (HFD) elevated oxidative stress/innate 
inflammation biomarkers in a young pig model. We performed a prevention study, where 64 pigs 
(n = 8/group), 3 weeks post-weaning, consumed one of the eight diets; standard control diet, 
HFD and HFD supplemented with purple or white-fleshed potato (raw, baked and chips, 10 % 
w/w) for 13 weeks. Potato diets had no effect on the average food intake and weight gain 
although the purple-fleshed potato baked group had numerically higher feed intake and weight 
gain compared to the other HFD groups. Irrespective of color/processing, pigs consuming potato 
diets had numerically lower oxidative stress ( GSH:GSSG ratio) and lower expression of 
inflammatory markers (NF-B, P = 0.04; TNF-α, P = 0.05; TLR-2, P = 0.05; TLR-4, P = 0.02; 
and COX-2, P = 0.03) in the distal colon mucosa compared to HFD controls. However, only the 





HFD control (P = 0.01). Similar results were obtained in the mesenteric fat – all the potato diet 
consuming animals had lower expression of TLR-4 (P = 0.05), NF-B (P = 0.05), and TNF-α (P 
= 0.03) compared to the HFD control. GSH:GSSG ratio was also elevated in all the purple-potato 
diet consuming groups and white raw group (P = 0.05) compared to the HFD control. Systemic 
markers of oxidative stress (8-isoprostane, P = 0.02; and 8-OHDG, P = 0.01), inflammation 
(TNF-α, P = 0.05; and IL-1β, P = 0.03) and serum triglycerides (P = 0.05) were suppressed in all 
the potato diet consuming animals compared to HFD control. However, there were no 
differences in the lipid profile (total cholesterol, LDL, HDL) or insulin/glucose among the HFD 
treatment groups. Results of this study suggest that potato consumption prevents HFD elevated 
oxidative stress and inflammatory biomarkers in the distal colon, mesenteric fat and the systemic 
circulation and there was only a marginal benefit of anthocyanin-rich potatoes over the 
traditional white-fleshed potatoes in this study. 
 
5.2 Introduction 
Consumption of a diet rich in fat and low in anti-oxidants is linked to elevated risk for  a 
variety of chronic disorders. Chronic low-grade oxidative stress and inflammation are conducive 
for development of disorders including colon cancer and are highly affected by diet (Wisse 2004, 
Chuang and McIntosh 2011). Once a medical rarity in children, disorders like inflammatory 
bowel disease (IBD), metabolic syndrome etc. are increasingly common in kids today. Genetic 
and environmental factors may be responsible for driving this rise. However, as genetic makeup 
does not change drastically in populations over short periods of time, it could be assumed that 





Poor eating habits, mainly due to easy access to and consuming oversized portions of the 
high-fat, high-calorie foods, juice and soda, and inactivity, are to blame for the rise in such 
chronic disorders in children (Han, Lawlor et al. 2010). Despite an increasing focus on the 
nutritional content of school meals and multiple initiatives at state and federal government scale, 
children are not meeting the recommended levels of fruit and vegetable consumption (Lin and 
Morrison 2002). Research indicates that children (as well as adults) who eat more fruits tend to 
have lower risk for chronic diseases during adulthood (Lin and Morrison 2002). Both fruits and 
vegetables are low-fat, if not, no-fat foods when consumed straight from the orchard or garden. 
Instead of consuming most of their fruits raw or in juices, unadorned with sauces or fried 
coatings or baked in pies, higher percentage of consumption of vegetables is in the form of deep-
fat frying, topped with high-fat dressings or sour cream, or including them in high-fat mixtures 
(Lin and Morrison 2002). The same is the case with the innocuous potato, which has been 
blamed for increasing risk for diabetes (Khosravi-Boroujeni, Mohammadifard et al. 2012). There 
is thus, a need for more research on the link between fruit and vegetable consumption and risk 
for chronic diseases with focus on how they are processed and consumed. 
High-fat diet (HFD) elevated oxidative stress can increase the susceptibility to chronic 
diseases by oxidizing cellular lipids, proteins, and DNA (Matsuzawa-Nagata, Takamura et al. 
2008, Fernandez-Sanchez, Madrigal-Santillan et al. 2011). Oxidative stress is involved in the 
link between chronic inflammation and cancer. In fact, the activation of NF-κB, a pro-
inflammatory molecule and a master regulator of inflammatory gene transcription, can be 
blocked by antioxidants, such as cysteine, N-acetylcysteine, vitamin C and E, anthocyanins, 
thiols, and green tea polyphenols (Schulze-Osthoff, Bauer et al. 1997, Carcamo, Pedraza et al. 





secretion of pro-inflammatory cytokines such as IL-1β, TNF-α and IL-6 by lymphocytes is 
responsible for initiating inflammation in the pathogenesis of chronic diseases such as 
atherosclerosis and rheumatoid arthritis (Monaco and Paleolog 2004).  
The potato (Solanum tuberosum L.) is the fourth-most extensively grown and consumed 
food crop across the world after wheat, rice and maize (FAO 2009). Potato is a carbohydrate-
rich, versatile vegetable prepared and served in a variety of ways world-wide. In addition to high 
concentrations of vitamin C and iron in the potato, the highly pigmented potato cultivars are rich 
in phenolic acids, anthocyanins, and carotenoids (Camire, Kubow et al. 2009). Indeed, we and 
others have shown that phenolic acids are present at amounts 5-12 times higher in purple-fleshed 
potatoes compared to their white-fleshed counterparts (Rodriguez-Saona, Giusti et al. 1998, 
Brown 2005, Madiwale, Reddivari et al. 2011, Radhakrishnan, Reddivari et al. 2011). However, 
unlike other anthocyanin-rich sources such as blueberries, potatoes are mostly processed before 
consumption (Brown 2005, Walton, Lentle et al. 2006, NPC 2007). It is well known that 
processing changes the physical and chemical composition of foods (Spanos, Wrolstad et al. 
1990, Price, Bacon et al. 1997), thus, affecting their antioxidant activity (Nicoli, Anese et al. 
1999, Dewanto, Wu et al. 2002). Analytical data from our lab suggested that metabolite profile 
of raw and baked potatoes were quite similar, however, the metabolite profile of chips was very 
different (Madiwale, Reddivari et al. 2012). However, it is critical to understand the effect of 
such processing techniques on the in vivo activity of the bioactive compounds in potatoes. 
We hypothesized that dietary supplementation with purple-fleshed potato (raw, baked 
and chips) will suppress the oxidative stress/inflammation biomarkers in the distal colon, 
mesenteric fat and systemic circulation in a pig model. Young pigs were provided with potato 





were measured. We used the pig as an animal model due to similar nutrient metabolism, and gut 
anatomy and physiology to humans (Cooper, Berry et al. 1997, Pond and Lei 2000). Results of 
the current study provide support for in vivo evidence for the health benefits of color-fleshed 
potatoes, with a focus on how it is processed. 
 
5.3 Materials and Methods 
All protocols for the use of animals in this study were approved by both the Colorado 
State University Institutional Animal Care and Use Committee (CSU-IACUC) and the North 




Sixty-four young (6 weeks old, breed: SPG) male pigs were obtained from Murphy-
Brown LLC (Warsaw, NC) and were housed individually in solid concrete floor indoor pens at 
the North Carolina State University Swine Educational Unit (Clayton, NC). The animals were 
divided into 8 groups so that mean initial body weight was similar among the treatment groups (n 
= 8 animals/treatment). Prior to the experimental study period of 13 weeks, there was a weaning 
period of 3 weeks and a nursery diet period of 3 weeks. All the animals completed the study and 
no adverse side effects were reported. 
 
5.3.2 Experimental Diets 
Each group was given one of the following diets: Standard control diet (C1, ~5 % fat), a 





fat content as the HFD and 10 % of either purple or white-fleshed potato (raw, baked or chips). 
For the chipped diets, the fat percentage was adjusted to match the other diets. We conducted a 
dose response study (Chapter IV) for anti-inflammatory effects of purple-fleshed potato chips in 
an obese pig model and found no difference in 10 and 20 % dose in alteration of HFD elevated 
inflammatory markers. Thus, 10 % was the dose used in this study.   
Purple-fleshed potatoes (Purple Majesty) and white-fleshed potatoes (Atlantic) were 
grown at Black Gold Farms (Pearsall, TX) and chips were prepared at Kettle Chips (Kettle, 
Salem, OR). Raw and baked potatoes were freeze dried at Vandrunen Farms, Illinois, prior to 
incorporation in the diet. Corn and dry fat were used as a major energy source, and soybean meal 
was the major protein source. Ratios between corn and soybean meal were adjusted to match 
energy and protein contents among diets. White corn was used to prevent carotenoids from 
yellow corn to affect the study. Composition of all the diets is presented in Table 5.1. Pigs 
consumed the experimental diets for 13 weeks; the feed and drinking water were provided ad 
libitum. Body weight, weight gain and feed intake were measured every week during the 



























C1 C2 PR WR PB WB PC WC 
Corn 75.75 56.39 46.09 46.09 46.09 46.09 49.5 49.5 
Purple-fleshed potato 0 0 10 0 10 0 10 0 
White-fleshed Potato 0 0 0 10 0 10 0 10 
Soybean meal w/o hulls 21 21 21 21 21 21 21 21 
L-Threonine 0 0.05 0.01 0.01 0.01 0.01 0.05 0.05 
L-Lysine HCl 0.15 0.2 0.15 0.15 0.15 0.15 0.18 0.18 
DL-Methionine 0 0.06 0.05 0.05 0.05 0.05 0.07 0.07 
Total minerals 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 
Salt 0.32 0.32 0.32 0.32 0.32 0.32 0.32 0.32 
Vitamin mix 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
Poultry fat 1 3 3 3 3 3 3 3 
Dry fat 0 17.1 17.5 17.5 17.5 17.5 14 14 
Dicalcium Phosphate 0.9 1 1 1 1 1 1 1 
Limestone 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 





Composition (% unless mentioned) 
Dry matter 89.6 91.7 92.6 92.6 92.6 92.6 92.2 92.2 
Metabolizable energy (Cal/kg) 3388 4278 4300 4300 4300 4300 4221 4221 
Crude protein 16.4 14.9 15.2 15.2 15.2 15.2 14.7 14.7 
Lysine 0.84 0.84 0.84 0.84 0.84 0.84 0.83 0.83 
Methionine 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
Tryptophan 0.16 0.15 0.16 0.16 0.16 0.16 0.15 0.15 
Threonine 0.52 0.52 0.52 0.52 0.52 0.52 0.52 0.52 
Fat 4.7 23 23 23 23 23 23 23 
Calcium 0.6 0.62 0.62 0.62 0.62 0.62 0.62 0.62 
Phosphorus available 0.23 0.24 0.23 0.23 0.23 0.23 0.24 0.24 
Phosphorus total 0.52 0.48 0.47 0.47 0.47 0.47 0.48 0.48 
C1, standard control, C2, high-fat diet control, letters P and W indicate purple and white-fleshed potato groups, R, B & C indicate 







5.3.3 Blood, Urine and Tissue Collection 
The animals were fasted for 4-6 hours prior to sacrifice. The animals were euthanized 
using captive bolt method. At termination, jugular vein blood was collected without 
anticoagulant and serum was stored at −80 °C for biochemical analysis. Insulin, glucose and 
lipid analysis were performed on serum samples collected at week 11 where the animals were 
fasted for 12 hours. Urine was collected at the end of the study in 15 ml falcon tubes. Once 
collected, urine samples were snap frozen and transferred to −80 °C for long term storage prior 
to analysis. Two cm of the distal colon was resected and cleaned with RNAse-free phosphate-
buffered saline (PBS). The mucosa was scraped using a glass slide into an RNAse free tube. The 
mucosa and the mesenteric fat were snap-frozen in liquid nitrogen and stored at −80 °C until 
analysis. 
 
5.3.4 Tissue Oxidative Stress  
Glutathione levels (GSH: reduced and GSSG: oxidized) were measured in the distal 
colon mucosa and mesenteric fat using UPLC/PDA (Waters ACQUITY UPLC H-Class) 
according to the HPLC method of Yilmaz et al (Yilmaz, Keser et al. 2009) with minor 
modifications.  
 
5.3.5 Real Time Polymerase Chain Reaction 
Real-time PCR analysis was used to measure the gene expression of pro-inflammatory 
and anti-inflammatory markers in the distal colon mucosa and the mesenteric fat. Total RNA was 
extracted using the Phenol-Free Total RNA Purification Kit (Amresco, Solon, OH) and cDNA 





Gaithersburg, MD), according to the manufacturer’s instructions. Real-time PCR was performed 
using qPCR SYBR green supermix (Quanta Biosciences) on an Illumina Eco instrument (San 
Diego, CA) and mRNA expression of genes were calculated using the Eco software (Illumina). 








Table 5.2 Primers used in the manuscript for real time PCR. 
Gene Forward Primer Sequence  Reverse Primer Sequence  Product Length (bp) 
Actin GGCCGGGACCTGACCGACTA GGAGGAGGAGGAGGCGGCC 162 
Adiponectin GCGAATGGGCATGTTAGGGA AAATCCGGGGCAGAAAAGGA 107 
COX-2 CATTGATGCCATGGAGCTGTA CTCCCCAAAGATGGCATCTG 70 
IL-10 TGATGGGGAGGATATCAAGG TGATGGGGAGGATATCAAGG 150 
NF-B CCCATGTAGACAGCACCACCTATGAT ACAGAGGCTCAAAGTTCTCCACCA 132 
TGF-β CGAGCCCTGGATACCAACTA AGGCTCCAGATGTAGGGACA 164 
TLR-2 CAGTCCGGAGGTTGCATATT ATGCTGTGAAAGGGAACAGG 137 
TLR-4 ATGGCCTTTCTCTCCTGCCTGA AGGTCCAGTATCTTGACTGATGTGGG 139 






5.3.6 Systemic Oxidative Stress Markers 
Urine samples were analyzed for 8-isoprostane and DNA adduct 8-hydroxy-2′-
deoxyguanosine following manufacturer’s protocol (Cayman, Ann Harbor, MI). Urinary 
concentrations were normalized to creatinine levels measured using a colorimetric kit (Cayman). 
Serum samples were analyzed for oxidative stress marker, 8-isoprostane – free and bound 
following the manufacturer’s protocol (Cayman). Serum oxygen radical absorbance capacity 
(ORAC) was calculated based on the method of Huang et al. (Huang, Ou et al. 2002). 
 
5.3.7 Serum Inflammatory Markers 
Inflammatory markers, TNF-α (Swine ELISA, Life Technologies, Grand Island, NY) and 
lipopolysaccharide (LPS, Limulus Amebocyte Lysate Kit, Lonza, Basel Switzerland) were 
analyzed in the serum based on the manufacturer’s protocols. IL-1β was measured in the serum 
using Milliplex Luminex based multiplex immnoassay method (Millipore, Billerica, MD). 
Insulin was measured using a radioimmunoassay following the manufacturer’s protocol 
(Millipore). Glucose was measured using a commercially available kit (Cayman) following 
standard recommended protocol. Both insulin and glucose were measured after a 12 hour fast at 
week 11 of the study. Serum lipid profile (Total Cholesterol, HDL, LDL and Triglycerides) were 
also measured at week 11 using standard protocols on a Beckman - Olympus AU400e Chemistry 
Analyzer at the University of Colorado Hospital. 
 
5.3.8 Statistical Analysis 
Completely randomized block design was used in this study. Individual pigs were the 









5.4.1 Physical Parameters  
Initial body weight of pigs did not differ among treatments. There were no significant 
differences in the overall feed intake/day and weight gain/day among the HFD treatment groups 
at the end of the study (Table 5.3). It should be noted that the overall feed conversion ratio, feed 
consumed/weight gain, did not differ among the all treatment groups at the end of the study 
(Appendix IV). There were no differences in the weight at the end of the study among the HFD 
treatment groups (excluding PB, P ≤ 0.05). No significant differences were observed among 
treatment groups in back-fat thickness (Appendix V). All the animals completed the study, and 








Table 5.3 Body weight (in kg, top panel), average daily gain (in kg/day, middle panel) and average daily feed intake (in kg/day, 
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2 ±          
0.1 a 
2.4 ±  
0.1 a 
2.2 ±  
0.1 a 
3.1 ±  
0.2 a 
2.3 ±  
0.2 a 


















1.6 ±  
0.2 b 
2 ±     
0.1 b 
1.7 ±  
0.1 b 
2.7 ±  
0.2 ab 
2.2 ±   
0.1 a 




















1.6 ±  
0.2 b 
2.1 ±  
0.2 ab 
1.7 ±  
0.2 b 
2.4 ±  
0.3 b 
2 ±     
0.2 a 




















1.5 ±  
0.1 b 
2.1 ±  
0.1 ab 
1.9 ±  
0.1 ab 
2.3 ±  
0.2 b 
1.9 ±  
0.2 a 




















1.7 ±  
0.1 b 
2.6 ±  
0.1 a 
2.2 ±  
0.2 b 
2.9 ±  
0.2 a 
2.4 ±  
0.2 a 




















1.6 ±  
0.1 b 
2.2 ±  
0.1 ab 
2 ±     
0.2 ab 
2.7 ±  
0.2 ab 
2 ±     
0.1 a 




















1.6 ±  
0.2 b 
2.2 ±  
0.2 ab 
2.2 ±  
0.2 ab 
2.9 ±  
0.2 b 
2.4 ±  
0.2 a 




1.9 ±              















1.9 ±  
0.1 ab 
2.4 ±  
0.1 a 
1.7 ±  
0.1 b 
2.8 ±  
0.3 ab 
2.2 ±  
0.2 a 








































5 ±     
0.2 a 
5.2 ±  
0.2 a 
4.9 ±   
0.2 a 
6.2 ±  
0.2 a 
6.3 ±  
0.2 a 




















3.8 ±  
0.1 b 
3.6 ±  
0.2 b 
4.4 ±  
0.3 b 
4.8 ±  
0.3 b 


















3.8 ±  
0.2 b 
4.1 ±   
0.3 b 
3.7 ±  
0.4 b 
4.4 ±  
0.4 b 
4.7 ±  
0.4 b 


















3.9 ±  
0.1b 
4.1 ±  
0.1 b 
4.1 ±  
0.2 b 
4.5 ±  
0.2 b 
4.7 ±  
0.2 b 


















4.1 ±  
0.1 b 
4.8 ±  
0.1 a 
4.5 ±  
0.2 a 
5.3 ±  
0.3 c 
5.6 ±  
0.2 c 


















3.8 ±  
0.2 b 
4.2 ±  
0.2 b 
4.2 ±  
0.2 ab 
4.8 ±  
0.3 bc 
4.9 ±  
0.2 b 


















3.6 ±  
0.2 b 
3.9 ±  
0.2 b 
3.9 ±  
0.2 b 
4.6 ±  
0.2 b 
4.9 ±  
0.2 b 




3.7 ±         
0.1 b 











4 ±     
0.1b 
4.2 ±  
0.2 b 
3.5 ±  
0.2 b 
4.3 ±  
0.3 b 
4.7 ±  
0.2 b 




3.9 ±         
0.1 b 
Results were expressed as mean ± SE for 7-8 animals in each treatment group. Means in columns (within a week between treatment groups) that differ by a common letter (a, b, c) differ (P 
≤ 0.05). C1, standard control, C2, high-fat diet control, letters P and W indicate purple and white-fleshed potato diets, R, B & C indicate processing treatments raw, baked and chips, 




5.4.2 Colonic GSH:GSSG Ratio 
Glutathione is an intracellular anti-oxidant in cells. Glutathione exists in two forms 
reduced (GSH) and oxidized (GSSG). Almost 90 % of glutathione exists in the reduced form, 
however, in conditions of oxidized stress, GSSG content of the cells increases. Therefore, a 
suppressed ratio of GSH:GSSG is an indicator of elevated oxidative stress (Owen and Butterfield 
2010). We measured GSH:GSSG ratio in the distal colon of the animals. All the potato groups 
irrespective of color/processing had levels similar to the standard diet animals. Only the PR 
group had significantly higher GSH:GSSG ratio compared to the HFD control (P = 0.01, Figure 
5.1).  
 
Figure 5.1. Reduced (GSH) and oxidized (GSSG) glutathione were measured in the distal colon 
mucosa using UPLC/PDA. Results were expressed as mean ± S.E. for 7-8 animals in each 
treatment group. Means that differ by a common letter (a, b) differ (P ≤ 0.05). C1, standard 
control, C2, high-fat diet control, letters P and W indicate purple and white-fleshed potato diets, 





5.4.3 Colonic Inflammatory Markers 
We measured relative expression of innate inflammatory markers TLRs 2, 4 and NF-B 
in the distal colon mucosa of the animals using quantitative real-time PCR. Expression of TLRs 
2, 4 and NF-B were elevated in the HFD group compared to standard animals. All the animals 
consuming potato diets had suppressed TLRs 2, 4 and NF-B expression compared to levels in 
HFD animals, to levels similar to the standard group (P = 0.05, P = 0.02, and P = 0.04, 
respectively, Figure 5.2A). Similar results were obtained for TNF-α and COX-2 (P = 0.05 and P 
= 0.03, respectively, Figures 5.2B). Combined with the results obtained in GSH:GSSG ratio, we 
show that bioactive components (e.g. phenolic acids, vitamin C, resistant starch etc.) in the 
white-fleshed potatoes were sufficient to prevent HFD induced oxidative stress/inflammation in 
the distal colon. In addition, experimental diets did not alter the relative expression of anti-








Figure 5.2A Relative expression of TLR-4, NF-кB and TLR-2 as measured using real time PCR 
in the distal colon mucosa. Results were expressed as mean ± S.E. for 7-8 animals in each 
treatment group. Means that differ by a common letter (a, b) differ (P ≤ 0.05). C1, standard 
control, C2, high-fat diet control, letters P and W indicate purple and white-fleshed potato diets, 






Figure 5.2B Relative expression of TNF-α and COX-2 as measured using real time PCR in the 
distal colon mucosa. Results were expressed as mean ± S.E. for 7-8 animals in each treatment 
group. Means that differ by a common letter (a, b) differ (P ≤ 0.05). C1, standard control, C2, 
high-fat diet control, letters P and W indicate purple and white-fleshed potato diets, R, B & C 
indicate processing treatments raw, baked and chips, respectively at 10 % supplementation.  
 
Figure 5.3 Relative expression of IL-10 and TGF-β as measured using real time PCR in the 
distal colon mucosa. Results were expressed as mean ± S.E. for 7-8 animals in each treatment 




high-fat diet control, letters P and W indicate purple and white-fleshed potato diets, R, B & C 
indicate processing treatments raw, baked and chips, respectively at 10 % supplementation.  
 
5.4.4 Mesenteric Fat GSH:GSSG Ratio 
In the mesenteric fat, there were no significant differences in the GSH:GSSG ratio, a 
marker of oxidative stress, between the standard control group and the HFD group. All the 
animals consuming purple-fleshed potato (PR, PB and PC) and the animals consuming white-
fleshed potato (WR) had significantly elevated GSH:GSSG ratio compared to HFD control 
suggesting potent anti-oxidant efficacy of purple-fleshed potatoes in the distal colon even after 
processing (P = 0.05). GSH:GSSG ratio in the processed white-fleshed potato groups (WB, WC) 
was not significantly different from HFD control (Figure 5.4).  
 
Figure 5.4 Glutathione (GSH-reduced and GSSG-oxidized) were measured in the mesenteric fat 
using UPLC/PDA. Results were expressed as mean ± S.E. for 7-8 animals in each treatment 
group. Means that differ by a common letter (a, b) differ (P ≤ 0.05). C1, standard control, C2, 
high-fat diet control, letters P and W indicate purple and white-fleshed potato diets, R, B & C 




5.4.5 Mesenteric Fat Inflammatory Markers 
We measured relative expression of the innate inflammatory markers in the mesenteric 
fat. Animals consuming HFD had elevated TLR-4 and NF-B expression compared to standard 
animals. All the animals on potato diets had significantly suppressed TLR-4 and NF-B 
expression compared to animals on HFD (Figure 5.5A) suggesting an anti-inflammatory role of 
potato, even after processing. Expression of pro-inflammatory cytokine TNF-α was elevated in 
the HFD group compared to standard animals. All the animals on the potato diets had suppressed 
TNF-α expression compared to levels in HFD animals (P = 0.03, Figure 5.5B). Mesenteric fat 
expression of adiponectin, an anti-inflammatory adipokine, was not significantly altered between 
groups (Figure 5.5B). In addition, we measured mesenteric fat relative expression of anti-
inflammatory cytokines IL-10 and TGF-β. We found no significant differences among the 
groups (Figure 5.6).  
 
Figure 5.5A Relative expression of TLR-4 and NF-B as measured using real time PCR in the 
mesenteric fat. Results were expressed as mean ± S.E. for 7-8 animals in each treatment group. 




diet control, letters P and W indicate purple and white-fleshed potato diets, R, B & C indicate 
processing treatments raw, baked and chips, respectively at 10 % supplementation.  
 
Figure 5.5B Relative expression of TNF-α and adiponectin as measured using real time PCR in 
the mesenteric fat. Results were expressed as mean ± S.E. for 7-8 animals in each treatment 
group. Means that differ by a common letter (a, b) differ (P ≤ 0.05). C1, standard control, C2, 
high-fat diet control, letters P and W indicate purple and white-fleshed potato diets, R, B & C 
indicate processing treatments raw, baked and chips, at 10 % supplementation.  
 
Figure 5.6 Relative expression of IL-10 and TGF-β as measured using real time PCR in the 




Means that differ by a common letter differ (P ≤ 0.05). C1, standard control, C2, high-fat diet 
control, letters P and W indicate purple and white-fleshed potato diets, R, B & C indicate 
processing treatments raw, baked and chips, respectively at 10 % supplementation.  
 
5.4.6 Systemic Oxidative Stress 
Systemic oxidative stress biomarkers were measured in serum/urine at the end of the 
study. Urinary 8-isoprostane concentrations, normalized to creatinine levels, were elevated in the 
HFD group compared to standard animals (Figure 5.7A). All the potato diets consuming animals 
had lower urinary 8-isoprostane concentrations, suggesting potato diets suppressed systemic 
oxidative stress (P = 0.02). Similar to 8-isoprostane, urinary 8-OHDG, DNA adduct, was also 
elevated in the HFD control group compared to standard control; all the potato diet consuming 
animals had lower urinary 8-OHDG compared to the HFD group (P = 0.01, Figure 5.7A). In 
addition, the levels of urinary 8-isoprostane and 8-OHDG in the potato groups were similar to 
the standard diet group animals (Figure 5.7A). We measured serum concentrations of 8-
isoprostane (free and bound), however, there were no significant differences among the treatment 
groups (Appendix VI). Potato consumption did not significantly elevate serum total anti-oxidant 





Figure 5.7A 8-isoprostane and 8-OHDG concentrations in porcine urine were measured using 
ELISA. Results were normalized to levels of creatinine. ELISA was performed according to 
manufacturer’s protocol (Cayman). Results were expressed as mean ± S.E. for 7-8 animals in 
each treatment group. Means that differ by a common letter (a, b, c) differ (P ≤ 0.05). C1, 
standard control, C2, high-fat diet control, letters P and W indicate purple and white-fleshed 
potato diets and R, B & C indicate processing treatments raw, baked and chips, respectively at 10 
% supplementation.  
 
5.4.7 Systemic Inflammatory Markers 
Systemic inflammation biomarkers were measured at the end of the study. Serum TNF-α 
concentration was significantly elevated in the HFD animals compared to standard control 
animals (Figure 5.7B). Similar to the oxidative stress markers, all the potato diets significantly 
suppressed serum TNF-α levels compared to the HFD controls (P = 0.05, Figure 5.7B). We also 
measured IL-1β, IL-4, IL-6, IL-8 and IL-10 in the serum of these animals using a porcine 
milliplex multiplex immunoassay. Trends in the level of IL-1β in the serum of pigs mirrored 




the animals on potato diets had suppressed serum IL-1β compared to HFD group (P = 0.03, 
Figure 5.7B). There were no significant differences between groups in serum concentrations of 
IL-4, IL-6, IL8 and IL-10 (data not shown). We measured insulin and glucose in the serum of 
these animals from week 11 of the study. There were no significant differences (Figure 5.7B) 
among the groups in serum insulin and glucose (P ≤ 0.05). 
 
Figure 5.7B TNF-α was measured in porcine serum using ELISA following manufacturers 
protocol (Life Technologies). IL-1β cytokine levels were measured in porcine serum using 
Millipore Milliplex kit following manufacturers protocol (Millipore). Insulin was measured 
using a radioimmunoassay following the manufacturers protocol (Millipore). Glucose was 
measured using a commercially available kit (Cayman). Results were expressed as mean ± SE 




0.05). C1, standard control, C2, high-fat diet control, letters P and W indicate purple and white-
fleshed potato diets, R, B & C indicate processing treatments raw, baked and chips, respectively 
at 10 % supplementation.  
 
 Serum lipids were measured to assess whether the potato diets improved the lipid profile 
of these animals. This profile was measured at week 11 of the study. There were no significant 
differences in the total cholesterol, HDL and LDL among the HFD consuming treatment groups. 
However, total cholesterol and HDL levels were significantly higher in the HFD animals 
compared to the levels in the standard diet animals (Figure 5.7C, P ≤ 0.05). The serum 
triglyceride levels followed similar trend of the inflammatory markers. The HFD control animals 
had elevated serum triglycerides compared to the standard control and all the potato diets 
consuming animals had significantly lower serum triglyceride levels compared to HFD control 







Figure 5.7C Serum lipids profile (Total cholesterol, HDL-direct, LDL and triglycerides) were 
measured on a Beckman-Olympus AU400e Chemistry Analyzer at the University of Colorado 
Hospital facility. Results were expressed as mean ± S.E. for 7-8 animals in each treatment group. 
Means that differ by a common letter (a, b) differ (P ≤ 0.05). C1, standard control, C2, high-fat 
diet control, letters P and W indicate purple and white-fleshed potato diets, R, B & C indicate 









Results of our earlier reversal study (Chapter IV) demonstrated that only the consumption 
of purple-fleshed potato suppressed oxidative stress and inflammatory markers in the distal 
colon, mesenteric fat and systemic circulation in HFD consuming pigs. Current results 
demonstrate that purple-fleshed potato supplementation in the diet of the HFD consuming young 
pigs prevented the increase in oxidative stress and inflammation biomarkers due to HFD 
consumption. White-fleshed potato consuming animals showed suppressed levels of oxidative 
stress and inflammation markers compared to the HFD controls. Results suggest that potato diets 
retain anti-oxidant and anti-inflammatory properties in vivo even after processing. 
 
5.5.1 Purple-Fleshed Potato Prevented Colonic and Mesenteric Fat Oxidative Stress 
(GSH:GSSG Ratio) in HFD Consuming Animals. 
Glutathione (GSH) is the most abundant anti-oxidant in aerobic cells, present in 
millimolar (mM) concentrations in tissue. GSH is critical for protecting various tissues from 
oxidative stress, acting as a free radical scavenger and is an inhibitor of lipid peroxidation. GSH 
participates in the detoxification of hydrogen peroxide by various glutathione peroxidases. When 
cells are exposed to increased levels of oxidative stress, GSSG will accumulate and the ratio of 
GSH to GSSG will decrease. Therefore, the determination of the GSH:GSSG ratio is a useful 
indicator of oxidative stress in animal and human tissues (Owen and Butterfield 2010). 
Our results demonstrate that only the animals consuming purple-fleshed potatoes (raw, 
PR) had significantly higher distal colonic GSH:GSSG ratio compared to HFD controls. 
GSH:GSSG ratio in the other groups including the standard control, were numerically higher but 




mesenteric fat were similar to colon. In the mesenteric fat, all the purple-fleshed potato groups 
(PR, PB and PC) and the WR group had significantly elevated GSH:GSSG ratio compared to the 
HFD control animals (P ≤ 0.05, Figure 5.4). These results suggest that potato supplementation 
resulted in the prevention of the increased oxidative stress markers in the HFD consuming 
animals. Although, low doses of phenolics are present in the white-fleshed potato, data suggests 
that it was sufficient to positively alter the glutathione redox status in the young animals. There 
was however, a marginal benefit of purple-fleshed potato consumption (Figure 5.1, 5.4). 
 
5.5.2 Purple and White-Fleshed Potato Prevented HFD Elevated Colonic and Mesenteric 
Fat Inflammatory Markers. 
HFD induced inflammation in the gut has been extensively explored in recent studies 
(Ding, Chi et al. 2010, Kim, Gu et al. 2012). HFD induced altered gut bacteria and TLR activation 
are key elements for induction of the innate inflammatory response via triggering signaling 
cascades including the transcription factor NF-B (Takeda and Akira 2004). Thus, we measured 
expression of TLR-2 (flagellin receptor), TLR-4 (LPS receptor) and NF-B in the colonic 
mucosa in these animals. Expression of TLR-2, TLR-4 and NF-B were suppressed in the potato 
consuming animals compared to the HFD control. In addition, these groups had levels similar to 
that of the standard animals suggesting an overall benefit of potato consumption (Figure 5.2A). 
We measured expression of TLR-4 and NF-B in the mesenteric fat. HFD controls had elevated 
expression of TLR-4 and NF-B compared to the standard controls in the mesenteric fat. All the 
potato diet consuming animals, irrespective of color/processing, had significantly lower 
expression levels of TLR-4 and NF-B compared to HFD controls, to levels similar to the 




Pro-inflammatory markers including cytokines such as IL-1β, TNF-α and IL-6 are 
increased in colitis in the colonic mucosa (Berg and Scherer 2005). Studies have suggested that 
adipokines secreted by adipose tissue (TNF-α, IL-6, adiponectin etc.) are closely associated with 
chronic inflammatory disorders such as ulcerative colitis (Li, Lelliott et al. 2008, Teixeira, 
Leonel et al. 2011). Thus, during inflammatory conditions of the colon such as colitis; both the 
colonic and the mesenteric fat show a pro-inflammatory profile (Li, Lelliott et al. 2008, Teixeira, 
Leonel et al. 2011) indexed by over-production of TNF-α (Zhang, Xu et al. 2006, Gambero, 
Marostica et al. 2007, Kim, Gu et al. 2012). In our study, results indicate that the potato 
consumption suppressed expression of TNF-α in both the distal colonic mucosa and the 
mesenteric fat compared to the HFD controls (Figure 5.2B, 5.5B). Levels in the potato groups 
were similar to the standard control. Mesenteric fat expression of adiponectin was not different 
among groups (Figure 5.5B).  
High dietary intakes of total fats, omega-6 fatty acids, and meat were shown to be 
associated with an increased risk of CD and UC, colonic inflammatory disorders. High fiber and 
fruit intakes were associated with decreased CD risk, and high vegetable intake was associated 
with decreased UC risk (Hou, Abraham et al. 2011). Bioactive compounds in potatoes such as 
anthocyanins and phenolic acids have shown anti-oxidant and anti-inflammatory properties in 
many models (Luceri, Guglielmi et al. 2004, Piberger, Oehme et al. 2011, Wu, Xu et al. 2011). 
Similarly, our results support an anti-inflammatory role of potato consumption. 
Since under homeostatic conditions a balance is maintained between pro- and anti-
inflammatory indices, we measured relative expression of anti-inflammatory cytokines IL-10 and 
TGF-β in the distal colon mucosa and the mesenteric fat of these animals. There were no 




TGF- β (Figure 5.3, 5.6) suggesting that potatoes exhibit anti-inflammatory action via targeting 
pro-inflammatory molecules. We measured expression of TLR-4, NF-B and TNF-α in the 
proximal colon and ileum mucosa of these animals. We did not detect any significant difference 
among the groups (Appendix VII). There were no differences even in the expression of TLR-4, 
NF-B and TNF-α between the standard and the HFD controls in the proximal colon and the 
ileum mucosa. This might suggest that HFD targets the distal colon in the pig model. Although, 
some studies support this observation (Lam, Mitchell et al. 2011), we are currently using 
advanced metabolomics and pyrosquencing (gut bacteria) methods to confirm this observation.    
 
5.5.3 Potato Diets Suppressed Systemic Oxidative Stress Markers in HFD Consuming 
Animals.  
8-Isoprostane is a prostaglandin-F2-like compound that belongs to the F2 isoprostane 
class. It is produced in vivo by the free radical-catalyzed peroxidation of arachidonic acid. 
Concentrations of 8-isoprostane, one of the more prevalent F2 isoprostanes, in the plasma/serum 
and urine are regarded as one of the best indices of lipid peroxidation, and oxidative stress that 
are currently available (Montuschi, Barnes et al. 2004). In our study, we measured 8-isoprostane 
in the serum, and in the urine of the HFD consuming pigs. All potato diets suppressed urinary 8-
isoprostane concentrations compared to HFD control (P = 0.02). In additions levels in the urine 
were similar to that of the standard control animals (Figure 5.7A). However, no significant 
differences were seen in serum 8-isoprostane concentrations among the treatments.  
8-hydroxydeoxyguanosine (8-OHdG), an oxidized nucleoside of DNA, is the most 
frequently detected and studied DNA adduct. Upon DNA repair, 8-OHdG is excreted in the urine 




cellular oxidative stress but might be a risk factor for cancer, atherosclerosis and diabetes (Wu, 
Chiou et al. 2004). In our study, urinary 8-OHDG concentrations followed a similar trend as 8-
isoprostane. The HFD controls had the highest 8-OHDG concentrations suggesting elevated 
oxidative stress. All the potato diet consuming animals had suppressed 8-OHDG concentrations, 
to the levels as standard controls (P = 0.01, Figure 5.7A). We measured serum anti-oxidant status 
using ORAC method. We did not observe any differences in the hydrophilic and lipophilic serum 
ORAC levels among groups (Appendix VI).   
 
5.5.4 Potato Diets Suppressed Systemic TNF-α and IL-1β in HFD Consuming Animals. 
Elevated concentrations of circulating cytokines TNF-α, IL-6 and IL-1β are considered a 
risk factor for disorders such as insulin resistance and cardiovascular diseases (Wisse 2004, Berg 
and Scherer 2005). A growing body of evidence suggests that the pro-inflammatory cytokines 
IL-1β and TNF-α play a critical role in the pathogenesis of inflammatory diseases (Antonelli, 
Ferri et al. 2009). TNF-α and IL-1β share several pro-inflammatory properties including the 
promotion of leukocyte-endothelium interaction, the activation of the arachidonic acid pathway, 
and the induction of cytokine production (Antonelli, Ferri et al. 2009). In our study, serum TNF-
α and IL-1β were suppressed in all the potato diet consuming animals compared to the HFD 
controls. Levels were similar to the standard controls suggesting that potato diets prevented HFD 
elevated systemic inflammatory markers (Figure 5.7B). We measured serum LPS, however, no 
differences were observed in serum LPS among the groups (Appendix VI). 
Previous studies on potatoes have shown that potato peel extracts reduced hyperglycemia, 
oxidative stress, and overall food consumption in diabetic rodents when consumed at 10 % of the 




control diabetic animals (Singh, Kamath et al. 2005, Singh, Kamath et al. 2005). Thus, we fasted 
the animals for 12 hours and collected serum to measure serum insulin/glucose. We did not 
observe any differences among groups in serum insulin or glucose. In fact, the levels of insulin in 
all groups were less than 5 mU/L which suggests that insulin levels were normal in these animals 
including the HFD controls (Figure 5.7B). To confirm, we measured expression of inflammatory 
markers NF-B and TNF-α in the liver of these animals. We did not observe any differences 
among groups in the expression of NF-B and TNF-α or the GSH:GSSG ratio in the livers of 
these animals (Appendix VII). In addition, we asked a trained pathologist to read the H&E slides 
of the livers of these animals. There were no signs of histological inflammation in the liver of 
these animals. Even after 13 weeks of HFD feeding, lack of liver inflammation might explain no 
systemic dysfunction in insulin and glucose levels. Thus, the current model – domestic pigs 
protected against insulin resistance even after 13 weeks of HFD feeding (Sejersen, Sorensen et 
al. 2013). 
Rats consuming potato peels for 4 weeks showed lower plasma cholesterol (40 % 
decrease) and lower hepatic fat cholesterol (30 % decrease) compared with cellulose consuming 
rats (Lazarov and Werman 1996). Rats consuming a diet with 78 % potato for 3 weeks had lower 
plasma cholesterol and triglycerides and reduced liver cholesterol than control rats (Robert, 
Narcy et al. 2006). Therefore, we measured the lipid profile of serum in these animals. We did 
not see any significant differences within the HFD animals in total cholesterol, LDL and HDL 
levels. Levels of HDL and total cholesterol were higher in the HFD animals compared to the 
standard control animals (Figure 5.7C). Only the serum triglyceride levels were suppressed in the 
potato consuming animals compared to the HFD controls and were similar to that of the standard 




(Mersmann, Arakelian et al. 1979), even in the HFD controls, suggesting that there was no 
impairment in lipid metabolism in these animals. Lack of substantial differences between the 
standard control and the high-fat diet fed control animals suggests that the pig model used in the 
study is protected against high-fat diet induced dyslipidemia and insulin resistance in the time 
period employed (13 weeks). However, recently published research indicates that the young 
Göttingen minipig fed on a high-energy diet for 4 months (~ 16-17 weeks) is a better model for 
diet induced childhood/adolescent obesity and metabolic syndrome (Christoffersen, 
Golozoubova et al. 2013), thus future studies focusing on preventing HFD induced insulin 
resistance and dyslipidemia should focus on Göttingen minipigs as a model. 
 
5.6 Conclusions 
In conclusion, our study suggests that both purple and white-fleshed potatoes demonstrate 
anti-oxidant/anti-inflammatory properties – processes involved in progression of colon 
inflammation/cancer and other disorders. Consumption of purple-fleshed potato demonstrated 
only a marginal benefit over white-fleshed potatoes. However, our earlier reversal study revealed 
that only the consumption of purple-fleshed potato reversed detrimental effects of HFD in pigs. 
Results from both studies demonstrate that only the consumption of purple-fleshed potatoes 
could both prevent and reverse HFD elevated oxidative stress and inflammatory markers in HFD 
consuming pigs.  
Regardless of the health-benefits, the sensory attributes and consumer acceptance of these 
new color-fleshed cultivars should not be discounted. Earlier results on sensory analysis from our 
lab revealed consumers’ readiness to accept purple-fleshed potatoes provided they were educated 




Hence, purple-fleshed potatoes can be a healthier choice as they possess greater levels of 
bioactive compounds, even after processing, as compared with their white-fleshed counterparts. 
However, we should keep in mind that the potato should be a healthy component of a varied diet. 
As a starch food item, it should be consumed in moderation and without excess lipid additions. 
Potato servings do not in themselves promote obesity/related disorders; excess starchy food, 
refined sugar and food laden with high calorie lipid additions might be the culprit (Brown 2005, 
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SUMMARY AND CONCLUSIONS 
 
6.1 In vitro Study 
Our results demonstrated that suppression of proliferation and elevation of apoptosis in 
HCT-116 p53+/+ human colon cancer cell lines at 100 µM or higher concentrations of RSV 
could be accomplished at 25 µM, when combined with GSE at doses of 35-50 µg/ml. These 
results strongly support our hypothesis that combining bioactive compounds like RSV and GSE 
could reduce the dose of either compound while providing similar or better anti-colon cancer 
properties. This lends support to the proposal that combinatorial approach towards colon cancer 
chemoprevention using bioactive compounds is a feasible approach – however, in vivo studies of 
such a RSV-GSE combination are clearly warranted.  
RSV-GSE combination induced G0/G1 phase arrest in HCT-116 colon cancer cells. RSV 
potentiated GSE induced p53 dependent apoptosis via mitochondrial apoptotic signaling as it 
involved interplay of reactive oxygen species, p53, Bax/Bcl-2 and caspase-3 pathways. 
Combination of RSV and GSE suppressed proliferation and induced apoptosis even in presence 
of IGF-1, suggesting its potential as a chemopreventive agent against colon cancer even in obese 
subjects. Moreover, RSV-GSE demonstrated specificity as the combination did not alter cell 
kinetics in the normal colonic epithelial cell line CRL-1831. Given the superior in vitro activity, 
further in vivo confirmation, using spontaneous or sporadic colon cancer mice models, of the 






6.2 Animal Study 
In the prevention study, both purple and white-fleshed potato (raw, baked and chips) 
consuming animals had lower distal colonic oxidative stress (measured using GSH:GSSG ratio, 
significant for purple-fleshed potato raw group) and significantly lower distal colonic expression 
of innate pro-inflammatory markers including TLRs 2, 4, NF-B, TNF-α, and COX-2, compared 
to the high-fat diet (HFD) controls (P < 0.05). The levels in the animals consuming potato diets 
were similar to the standard control animals. Similarly, in the mesenteric fat, oxidative stress 
(GSH:GSSG ratio) was lower (only numerical suppression in WB and WC groups), and 
expression levels of TLR-4, NF-B and TNF-α were significantly suppressed in all the potato 
diet consuming animals compared to the HFD controls. Moreover, the animals consuming potato 
diets had significantly lower systemic oxidative stress markers (measured using urinary 8-
isoprostane and 8-OHDG) and circulating pro-inflammatory cytokines (TNF-α and IL-1β) 
compared to the HFD control animals similar to levels observed in the standard control animals 
(P < 0.05).  
However, in the reversal study, only the purple-fleshed potato consuming animals had 
significantly lower distal colonic oxidative stress (GSH:GSSG ratio) and lower distal colonic 
expression of innate inflammatory markers (TLRs 2, 4, NF-B, and TNF-α) compared to HFD 
controls. Levels of these markers in the animals consuming white-fleshed potatoes were not 
significantly different from the HFD controls. Only the animals consuming purple-fleshed potato 
diets had lower expression of TNF-α and higher expression of adiponectin in the mesenteric fat 
compared to the HFD control. Anti-inflammatory/anti-oxidant effect of the purple-fleshed potato 
in the mesenteric fat was only modest in the reversal study. The purple-fleshed potato consuming 




white-fleshed potato group were not significantly different from HFD control. Serum TNF-α, a 
pro-inflammatory cytokine, however, was suppressed in both purple and white-fleshed groups 
(W10) compared to the HFD control.  
Results of our study demonstrate that only purple-fleshed potato, even after processing, 
prevented and reversed HFD induced oxidative stress/inflammation markers in the distal colon, 
mesenteric fat and systemic circulation in the pig, a human relevant animal model. The 
differences between the purple and white-fleshed potatoes could be explained by the differences 
in their phenolic metabolic profiles as identified using UPLC/MS analysis. However, white-
fleshed potato (rich in phenolic acids) was effective in preventing HFD elevated oxidative 
stress/inflammation markers in the distal colon, mesenteric fat and systemic circulation. Vitamin 
C, phenolic acids and resistant starches present in the white-fleshed potatoes could have 
mediated the health benefits, however further research to elucidate their contributions is required. 
Overall results suggest that purple-fleshed potatoes are a great delivery vehicle for anti-
inflammatory and anti-oxidant bioactive compounds – may potentially reduce risk for systemic 














Growth performances (feed conversion ratio and back-fat thickness in mm) of pigs consuming experimental diets during the 5 week 
feeding period in the reversal study. 
Dietary Group Week 0 Week 1 Week 2 Week 3 Week 4 Week 5  
 Feed Conversion Ratio  
C  0.3 ± 0 0.3 ± 0 0.3 ± 0 0.2 ± 0 0.4 ± 0 0.3 ± 0 
P10  0.4 ± 0 0.2 ± 0.1 0.4 ± 0 0.3 ± 0 0.3 ± 0 0.3 ± 0 
P20  -0.7 ± 0.6 0.4 ± 0.1 0.3 ± 0.1 0.4 ± 0.1 0.3 ± 0 0.3 ± 0 
W10  0.3 ± 0.1 0.2 ± 0 0.3 ± 0 0.3 ± 0 0.3 ± 0 0.3 ± 0 
W20  -1.3 ± 1.1 0.1 ± 0.2 0.5 ± 0.1 0.2 ± 0.1 0.2 ± 0.1 0.3 ± 0 
Back-fat Thickness (mm) 
C 18.8 ± 0.2 17.2 ± 0.2 18.6 ± 0.2 18.5 ± 0.2    
P10 18.7 ± 0.3 17.7 ± 0.1 18.5 ± 0.3 18.5 ± 0.3    
P20 18.8 ± 0.3 17.3 ± 0.3 18.7 ± 0.3 18.6 ± 0.3    
W10 18.4 ± 0.1 17.7 ± 0.3 18.3 ± 0.1 18.2 ± 0.1    
W20 18.8 ± 0.2 17.5 ± 0.2 18.6 ± 0.2 18.5 ± 0.2    
Data are presented as means ± S.E. C: High-fat diet control, P10 and P20 - purple-fleshed potato chips at 10 and 20 % of diet w/w and W10 and W20 - 












Markers/Parameters C P10 P20 W10 W20 
Serum total oxygen radical absorbance capacity (µmol 
Trolox equivalents/L)  906.6 ± 45.2a 867.1 ± 46.2a 843.1 ± 43.2a 806.0 ± 28.7a 844.0 ± 42.3a 
Serum C-reactive protein (µg/mL) 11.2 ± 1.8a  10.7 ±1.2a 13.9 ±1.9a 11.9 ±3.2a 13.4 ±1.8a 
Serum lipopolysaccharide (ng/mL) 0.09 ± 0.02a 0.11 ± 0.05a 0.12 ± 0.04a 0.09 ± 0.03a 0.1 ± 0.04a 
Serum leukotriene B4 (pg/mL) 2390.0 ± 330.2ab 2054.2 ± 87.1a 2036.2 ± 153.7a 2117.1 ± 215.3ab 2573.1 ± 228.4b 
Urinary 8-hydroxy-2′-deoxyguanosine (ng/mg creatinine)  51.8 ± 8.9a  59.8 ± 10.3a 45.5 ±  5.9a 57.4 ± 9.4a 42.5 ± 6.0a 
Urinary 8-isoprostane (ng/mg creatinine) 0.9 ± 0.1a 1.2 ± 0.3a 1.3 ± 0.3a 1.1 ± 0.2a 1.2 ± 0.2a 
Data are presented as means ± S.E. Means in a row that differ by a common letter (a, b) differ (P < 0.05). C: High-fat diet control, P10 and P20 - purple-





Relative expression as measured using real time PCR in the ileum and the proximal colon mucosa in the reversal study.  
 
TLR-4 NF-κB TNF-α 
Dietary Group Ileum Mucosa 
C 1.9 ± 0.8 1.4 ± 0.4 1.6 ± 0.3 
P10 1.3 ± 0.7 1 ± 0.4 1 ± 0.3 
P20 2 ± 0.6 1.2 ± 0.4 0.9 ± 0.3 
W10 2.6 ± 0.6 1.4 ± 0.4 1.5 ± 0.3 
W20 1.5 ± 0.6 1 ± 0.4 1.3 ± 0.3 
 
Proximal Colon Mucosa 
C 0.9 ± 0.1 1.2 ± 0.2 0.9 ± 0.2 
P10 0.8 ± 0.1 0.8 ± 0.2 0.6 ± 0.3 
P20 0.9 ± 0.1 0.9 ± 0.2 0.6 ± 0.2 
W10 0.7 ± 0.1 0.6 ± 0.4 0.5 ± 0.2 
W20 0.8 ± 0.1 0.9 ± 0.2 1.4 ± 0.8 
Results were expressed as mean ± S.E. for 7-8 animals in each treatment group. C: High-fat diet control, P10 and P20 - 
purple-fleshed potato chips at 10 and 20 % of diet w/w and W10 and W20 - white-fleshed potato chips at 10 and 20 % of the 
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Data are presented as means ± S.E. C1, standard control, C2, high-fat diet control, letters P and W indicate purple and white-fleshed potato groups, R, B & C 
indicate processing treatments raw, baked and chips, respectively at 10 % supplementation. There were no differences between groups in the overall feed 
















Back-fat thickness (mm) of animals in the prevention study. Data are presented as means ± S.E of 8 animals per group.  
Dietary Group Week 1 Week 5 Week 8 Week 13 
 
Back-fat Thickness (inch) 
C1 7 ± 0.5 8.8 ± 0.5 12.4 ± 0.6 19.2 ± 1 
C2 7.2 ± 0.7 11.2 ± 0.8 14.4 ± 1 19.1 ± 1.3 
PR 7.4 ± 0.7 10.2 ± 0.7 14.7 ± 0.9 18.6 ± 1.4 
WR 8.1 ± 0.4 12.4 ± 0.7 16.5 ± 0.5 21.6 ± 1.2 
PB 7.2 ± 0.5 11.4 ± 0.6 16.5 ± 0.7 23.3 ± 0.6 
WB 7.3 ± 0.5 10.9 ± 1 15.5 ± 1.1 20.8 ± 1.9 
PC 7.1 ± 0.4 12.1 ± 0.7 17.1 ± 0.8 24.7 ± 1.5 
WC 7 ± 0.3 12.9 ± 1.1 18.8 ± 1.1 23.1 ± 1.9 
Data are presented as means ± S.E. There were no differences between groups at P ≤ 0.05.  C1, 
standard control, C2, high-fat diet control, letters P and W indicate purple and white-fleshed potato 
groups, R, B & C indicate processing treatments raw, baked and chips, respectively at 10 % 








Oxidative stress and inflammatory markers measured in porcine serum/urine at week 5 in the prevention study.  
Markers/Parameters C1 C2 PR WR PB WB PC WC 
Serum lipopolysacccharide 
(ng/mL) 0.3 ± 0 0.3 ± 0 0.3 ± 0 0.3 ± 0 0.3 ± 0 0.4 ± 0 0.4 ± 0 0.4 ± 0 

















Serum total oxygen radical 
absorbance capacity (µmol 
Trolox equivalents/L) 




531.7 ±  
77.8 
504.9 ±    
66.9 








Data are presented as means ± S.E. C1, standard control, C2, high-fat diet control, letters P and W indicate purple and white-fleshed potato groups, R, B & C 











GSH:GSSG ratio in the liver was measured using UPLC/PDA. Relative expression of TLR-4, NF-κB and TNF-α was measured using 
real-time PCR in the liver, ileum and the proximal colon mucosa in the prevention study.  
 
GSH:GSSG Ratio NF-κB TNF-α 
Dietary Group Liver 
C1 3.6 ± 0.3 1.3 ± 0.3 1.4 ± 0.5 
C2 3.7 ± 0.1 1.1 ± 0.3 1.2 ± 0.4 
PR 3.5 ± 0.4 0.9 ± 0.3 2.2 ± 0.6 
WR 3.3 ± 0.2 0.8 ± 0.3 1.1 ± 0.5 
PB 3.5 ± 0.3 1.4 ± 0.3 1.9 ± 1.5 
WB 4 ± 0.3 0.9 ± 0.3 2.1 ± 1.4 
PC 3.6 ± 0.2 1 ± 0.3 0.8 ± 0.5 
WC 3.3 ± 0.1 0.9 ± 0.3 1.2 ± 1 
 
TLR-4 NF-κB TNF-α 
 
Ileum Mucosa 
C1 1.3 ± 0.3 1.9 ± 0.3 0.5 ± 0.4 
C2 1 ± 0.3 1 ± 0.3 0.5 ± 0.4 
PR 1.7 ± 0.3 1.5 ± 0.3 1.2 ± 0.5 




PB 0.6 ± 0.3 0.8 ± 0.3 0.6 ± 0.4 
WB 1.5 ± 0.3 1.6 ± 0.3 0.4 ± 0.5 
PC 1.1 ± 0.3 1 ± 0.3 1.1 ± 0.4 
WC 1 ± 0.3 1.3 ± 0.3 1 ± 0.5 
 
TLR-4 NF-κB TNF-α 
 
Proximal Colon Mucosa 
C1 0.6 ± 0.5 0.8 ± 0.4 0.7 ± 0.2 
C2 0.6 ± 0.6 0.5 ± 0.5 1.2 ± 0.5 
PR 1.2 ± 0.5 1.2 ± 0.4 0.9 ± 0.3 
WR 0.5 ± 0.5 0.5 ± 0.4 1.1 ± 0.3 
PB 1 ± 0.5 0.9 ± 0.4 0.5 ± 0.4 
WB 0.5 ± 0.5 0.5 ± 0.4 0.4 ± 0.4 
PC 0.4 ± 0.5 0.4 ± 0.4 0.5 ± 0.3 
WC 0.6 ± 0.5 0.5 ± 0.4 0.9 ± 0.3 
Data are presented as means ± S.E. C1, standard control, C2, high-fat diet control, letters P 
and W indicate purple and white-fleshed potato groups, R, B & C indicate processing 
treatments raw, baked and chips, respectively at 10 % supplementation. There were no 









Akt: Protein Kinase B 
APC: Adenomatous polyposis coli 
ATM: Adipose tissue macrophages 
Bax: Bcl-2-associated X protein 
Bcl-2: B-cell lymphoma 2 protein 
CD: Crohn’s disease 
CI: Combination index 
COX-2: Cyclooxygenase-2 
CRC: Colorectal cancer 
DMEM: Dulbecco's modified eagle's medium  
FACS: Fluorescence activated cell sorting analysis  
FBS: Fetal bovine serum 
GSE: Grape seed extract 
GSH: Reduced glutathione 
GSSG: Oxidized glutathione 
HDL: High density lipoprotein 
HFD: High-fat diet 
IBD: Inflammatory bowel disease 
IFN-γ: Interferon- γ 




IGF-1R: Insulin like growth factor-1 receptor 






JNK: c-Jun N-terminal kinases 
LDH: Lactate-dehydrogenase  
LDL: Low density lipoprotein 
LPS: Lipopolysaccharide 
MCP-1: Monocyte chemotactic protein-1  
MDA: Malondialdehyde 
NAC: N-Acetyl cysteine 
NF-B: Nuclear factor kappa-light-chain-enhancer of activated B cells 
NO: Nitric oxide 
ORAC: Oxygen radical absorbance capacity  
PBS: Phosphate buffered saline 
RNS: Reactive nitrogen species 
ROS: Reactive oxygen species 
RSV: Resveratrol 
TGF-β: Transforming growth factor-β 




TLR-4: Toll-like receptor-4 
TNF-α: Tumor necrosis factor-α 
UC: Ulcerative colitis 
UPLC-MS: Ultra performance liquid chromatography – Mass spectrometry 
 
REVERSAL STUDY 
C: High-fat diet control 
P10 and P20: Purple-fleshed potato chips at 10 and 20 % of diet w/w.  
W10 and W20: White-fleshed potato chips at 10 and 20 % of the diet w/w. 
 
PREVENTION STUDY  
C1: Standard diet control 
C2: High-fat diet control,  
PR, PB, PC, WR, WB and WC: Letters P and W indicate purple and white-fleshed potato 
groups, R, B & C indicate processing treatments raw, baked and chips, respectively at 10% 
supplementation (w/w).  
 
